NORTH FORK BANCORPORATION INC
8-K, 1994-07-06
STATE COMMERCIAL BANKS
Previous: BURLINGTON NORTHERN INC/DE/, 8-K, 1994-07-06
Next: PRUDENTIAL EQUITY FUND, 497, 1994-07-06






                         SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C. 20549

                                      FORM 8-K

                            C U R R E N T   R E P O R T

                       Pursuant to Section 13 or 15(d) of the
                          Securities Exchange Act of 1934

                                   June 27, 1994  
                 Date of Report (Date Of Earliest Event Reported)

                          NORTH FORK BANCORPORATION, INC.
               (Exact Name Of Registrant As Specified In Its Charter)

                                     Delaware                    
                   (State Or Other Jurisdiction Of Incorporation)

                  0-10280                        36-3154608             
          (Commission File Number)      (IRS Employer Identification No.)

                     9025 Route 25, Mattituck, New York  11952
                (Address Of Principal Executive Offices) (Zip Code)

                                 (516) 298-5000                     
                (Registrant's Telephone Number, including Area Code)

                                 NOT APPLICABLE                         
           (Former Name Or Former Address, If Changed Since Last Report)



          ITEM 5.  OTHER EVENTS.

                    On June 27, 1994, North Fork Bancorporation,
          Inc. ("North Fork") and Metro Bancshares Inc. ("Metro")
          entered into an Agreement and Plan of Merger (the "Merger
          Agreement") providing, among other things, for the merger
          (the "Merger") of Metro with and into North Fork, with
          North Fork surviving the Merger (the "Surviving
          Corporation").  Immediately after the Merger, Bayside
          Federal Savings Bank ("Bayside Federal"), Metro's
          federally chartered savings bank subsidiary, will merge
          (the "Subsidiary Merger") with and into North Fork Bank
          ("New York Bank"), North Fork's New York chartered bank
          subsidiary.

                    Pursuant to the Merger Agreement, each share of
          the common stock, par value $0.01 per share ("Metro
          Common Stock"), of Metro outstanding on the date of the
          Merger (except for shares of Metro Common Stock held by
          Metro as treasury stock or shares held by North Fork or
          any of its subsidiaries, but including shares of Metro
          Common Stock (i) held directly or indirectly by North
          Fork or Metro or any of their respective subsidiaries in
          trust accounts, managed accounts and the like or
          otherwise held in a fiduciary capacity that are
          beneficially owned by third parties ("Trust Account
          Shares") and (ii) held by North Fork or Metro or any of
          their respective subsidiaries in respect of a debt
          previously contracted ("DPC Shares")) will be converted
          into a number of shares (the "Exchange Ratio") of the
          common stock, par value $2.50 per share, of North Fork
          ("North Fork Common Stock"), determined by dividing
          $25.50 by the "Average Closing Price," provided, however,
          that (I) if the Average Closing Price is equal to or
          greater than $15.50, the Exchange Ratio shall be 1.645
          and (II) except as described in the next sentence, if the
          Average Closing Price is equal to or less than $14.50,
          the Exchange Ratio shall be 1.759.  If the Average
          Closing Price is less than $12.50, Metro may terminate
          the Merger Agreement unless North Fork increases the
          Exchange Ratio such that the shares of North Fork Common
          Stock issued in exchange for each share of Metro Common
          Stock have a nominal value (valued at the Average Closing
          Price) of $21.99.  The Average Closing Price is defined
          as the average closing sales price of the North Fork
          Common Stock on the New York Stock Exchange for the 20
          consecutive trading days ending on the 5th business day
          prior to the date on which the last required regulatory
          approval for the Merger, the Subsidiary Merger and the
          other transactions contemplated by the Merger Agreement
          is obtained, without regard to any requisite waiting
          periods in respect thereof.  

                    The shares of North Fork Common Stock Common
          Stock issued in the Merger will include the corresponding
          number of rights attached to such shares pursuant to
          North Fork's shareholder rights plan.  No fractional
          shares of North Fork Common Stock will be issued in the
          Merger, and Metro stockholders who otherwise would be
          entitled to receive a fractional share of North Fork
          Common Stock will receive a cash payment in lieu thereof.

                    Consummation of the Merger is subject to
          certain conditions, including, but not limited to,
          approval of the Merger Agreement by the stockholders of
          each of Metro and North Fork and the receipt of all
          required regulatory approvals.  In addition, Metro may
          terminate the Merger Agreement during the first 30 days
          following its execution if Metro reasonably determines in
          good faith that the business or financial condition of
          North Fork and its subsidiaries taken as a whole has
          materially and adversely changed from that described in
          North Fork's Annual Report on Form 10-K for the fiscal
          year ended on December 31, 1993.  

                    As a condition to the execution and delivery of
          the Merger Agreement, North Fork and Metro entered into a
          stock option agreement, dated as of June 27, 1994 (the
          "Stock Option Agreement"), pursuant to which Metro
          granted North Fork an option to purchase up to 557,795
          shares of Metro Common Stock at a purchase price of
          $21.00 per share, subject to adjustment.  The option is
          exercisable only upon the occurrence of certain events
          described therein, none of which has occurred.  In
          addition, pursuant to the Merger Agreement, upon the
          occurrence of any such event, Metro will pay North Fork a
          termination fee of $2,000,000.  

                    The Merger Agreement and the Stock Option
          Agreement are attached hereto as exhibits and
          incorporated herein by reference in their entirety.  The
          foregoing summaries of the Merger Agreement and the Stock
          Option Agreement do not purport to be complete and are
          qualified in their entirety by reference to such
          exhibits.


          ITEM 7.  FINANCIAL STATEMENT AND EXHIBITS.

               (c)  Exhibits

                    The following Exhibits are filed with this
          Current Report on Form 8-K:

          Exhibit
          Number                   Description

            2.1          Agreement and Plan of Merger, dated as of
                         June 27, 1994, between North Fork
                         Bancorporation, Inc. and Metro Bancshares
                         Inc.

           99.1          Stock Option Agreement, dated as of June
                         27, 1994, between North Fork
                         Bancorporation, Inc. and Metro Bancshares
                         Inc.


                                  SIGNATURE

                    Pursuant to the requirements of the Securities
          Exchange Act of 1934, the registrant has duly caused this
          report to be signed on its behalf by the undersigned
          hereunder duly authorized.

          Dated:  July 6, 1994

                                   NORTH FORK BANCORPORATION, INC.

                                   By: /s/ Daniel M. Healy
                                   Name:   Daniel M. Healy
                                   Title:  Executive Vice President
                                           Chief Financial Officer



                                EXHIBIT INDEX

          Exhibit                                      Page
          Number              Description              Number

            2.1     Agreement and Plan of Merger, dated
                    as of June 27, 1994, between North
                    Fork Bancorporation, Inc. and Metro
                    Bancshares Inc.

           99.1     Stock Option Agreement, dated as
                    of June 27, 1994, between North Fork
                    Bancorporation, Inc. and Metro
                    Bancshares Inc.





                         AGREEMENT AND PLAN OF MERGER

                    AGREEMENT AND PLAN OF MERGER, dated as of June
          27, 1994, by and among North Fork Bancorporation, Inc., a
          Delaware corporation ("Buyer") and Metro Bancshares Inc.,
          a Delaware corporation (the "Company").  (Buyer and the
          Company are herein sometimes collectively referred to
          herein as the "Constituent Corporations".)

                    WHEREAS, the Boards of Directors of Buyer and
          the Company have determined that it is in the best
          interests of their respective companies and their
          shareholders to consummate the business combination
          transaction provided for herein in which the Company
          will, subject to the terms and conditions set forth
          herein, merge (the "Merger") with and into Buyer; and

                    WHEREAS, as soon as practicable after the
          execution and delivery of this Agreement, North Fork
          Bank, a New York chartered stock commercial bank and a
          wholly owned subsidiary of Buyer ("New York Bank", and
          sometimes referred to herein as the "Surviving Bank"),
          and Bayside Federal Savings Bank, a federally chartered
          stock savings bank and a wholly owned subsidiary of the
          Company (the "Company Bank"), will enter into a
          Subsidiary Agreement and Plan of Merger (the "Bank Merger
          Agreement") providing for the merger (the "Subsidiary
          Merger") of the Company Bank with and into New York Bank,
          and it is intended that the Subsidiary Merger be
          consummated immediately following the consummation of the
          Merger; and

                    WHEREAS, the parties desire to make certain
          representations, warranties and agreements in connection
          with the Merger and also to prescribe certain conditions
          to the Merger.


                    NOW, THEREFORE, in consideration of the mutual
          covenants, representations, warranties and agreements
          contained herein, and intending to be legally bound
          hereby, the parties agree as follows:

                                  ARTICLE I

                                  THE MERGER

                    1.1.  The Merger.  Subject to the terms and
          conditions of this Agreement, in accordance with the
          Delaware General Corporation Law (the "DGCL"), at the
          Effective Time (as defined in Section 1.2 hereof), the
          Company shall merge with and into Buyer.  Buyer shall be
          the surviving corporation (hereinafter sometimes called
          the "Surviving Corporation") in the Merger, and shall
          continue its corporate existence under the laws of the
          State of Delaware.  The name of the Surviving Corporation
          shall continue to be North Fork Bancorporation, Inc. 
          Upon consummation of the Merger, the separate corporate
          existence of the Company shall terminate. 

                    1.2.  Effective Time.  The Merger shall become 
          effective as set forth in the certificate of merger (the
          "Certificate of Merger") which shall be filed with the
          Secretary of State of the State of Delaware (the
          "Secretary") on the Closing Date (as defined in Section
          9.1 hereof).  The term "Effective Time" shall be the date
          and time when the Merger becomes effective, as set forth
          in the Certificate of Merger.

                    1.3.  Effects of the Merger.  At and after the
          Effective Time, the Merger shall have the effects set
          forth in Sections 259 and 261 of the DGCL.

                    1.4.  Conversion of Company Common Stock.

                         (a)  At the Effective Time, subject to
          Section 2.2(e) hereof, each share of the common stock,
          par value $0.01 per share, of the Company (the "Company
          Common Stock") issued and outstanding immediately prior
          to the Effective Time (other than shares of Company
          Common Stock held (x) in the Company's treasury or (y)
          directly or indirectly by Buyer or the Company or any of
          their respective Subsidiaries (as defined below) (except
          for Trust Account Shares and DPC shares, as such terms
          are defined in Section 1.4(b) hereof)) shall, by virtue
          of this Agreement and without any action on the part of
          the holder thereof, be converted into and exchangeable
          for the number of shares (the "Exchange Ratio") of the
          common stock, par value $2.50 per share, of Buyer ("Buyer
          Common Stock") (together with the number of Buyer Rights
          (as defined in Section 4.2 hereof) associated therewith),
          determined by dividing $25.50 by the Average Closing
          Price (as defined below); provided, however, that (I) if
          the Average Closing Price is equal to or greater than
          $15.50, the Exchange Ratio shall be 1.645 (the "Minimum
          Exchange Ratio") and (II) subject to the provisions of
          Section 8.1(g) hereof, if the Average Closing Price is
          equal to or less than $14.50, the Exchange Ratio shall be
          1.759 (the "Maximum Exchange Ratio").  As used herein,
          the term "Average Closing Price" means the average
          closing sales price per share of Buyer Common Stock on
          the New York Stock Exchange ("NYSE") (as reported by The
          Wall Street Journal or, if not reported thereby, another
          authoritative source), for the 20 consecutive NYSE
          trading days (the "Valuation Period") ending on the fifth
          business day prior to the date on which the last of all
          regulatory approvals required to consummate the
          transactions contemplated hereby (including the Merger
          and the Subsidiary Merger) are obtained, without regard
          to any requisite waiting periods in respect thereof.  All
          of the shares of Company Common Stock converted into
          Buyer Common Stock pursuant to this Article I shall no
          longer be outstanding and shall automatically be
          cancelled and shall cease to exist, and each certificate
          (each a "Certificate") previously representing any such
          shares of Company Common Stock shall thereafter only
          represent the right to receive (i) the number of whole
          shares of Buyer Common Stock and (ii) the cash in lieu of
          fractional shares into which the shares of Company Common
          Stock represented by such Certificate have been converted
          pursuant to this Section 1.4(a) and Section 2.2(e)
          hereof.  Certificates previously representing shares of
          Company Common Stock shall be exchanged for certificates
          representing whole shares of Buyer Common Stock and cash
          in lieu of fractional shares issued in consideration
          therefor upon the surrender of such Certificates in
          accordance with Section 2.2 hereof, without any interest
          thereon.  If prior to the Effective Time Buyer should
          split or combine its common stock, or pay a dividend or
          other distribution in such common stock, then the
          Exchange Ratio, Minimum Exchange Ratio and Maximum
          Exchange Ratio shall be appropriately adjusted to reflect
          such split, combination, dividend or distribution.

                         (b)  At the Effective Time, all shares of
          Company Common Stock that are owned by the Company as
          treasury stock and all shares of Company Common Stock
          that are owned directly or indirectly by Buyer or the
          Company or any of their respective Subsidiaries (other
          than shares of Company Common Stock (x) held directly or
          indirectly in trust accounts, managed accounts and the
          like or otherwise held in a fiduciary capacity that are
          beneficially owned by third parties (any such shares, and
          shares of Buyer Common Stock which are similarly held,
          whether held directly or indirectly by Buyer or the
          Company, as the case may be, being referred to herein as
          "Trust Account Shares") and (y) shares of Company Common
          Stock held by Buyer or the Company or any of their
          respective Subsidiaries in respect of a debt previously
          contracted (any such shares of Company Common Stock, and
          shares of Buyer Common Stock which are similarly held,
          whether held directly or indirectly by Buyer or the
          Company being referred to herein as "DPC Shares")) shall
          be cancelled and shall cease to exist and no stock of
          Buyer or other consideration shall be delivered in
          exchange therefor.  All shares of Buyer Common Stock that
          are owned by the Company or any of its Subsidiaries
          (other than Trust Account Shares and DPC Shares) shall
          become treasury stock of Buyer.

                    1.5.  Stock Options.  (a) At the Effective
          Time, each option granted by the Company (a "Company
          Option") to purchase shares of Company Common Stock which
          is outstanding and unexercised immediately prior thereto
          shall, except as otherwise provided in Section 1.5(b)
          hereof, be converted automatically into an option to
          purchase shares of Buyer Common Stock in an amount and at
          an exercise price determined as provided below (and
          otherwise subject to the terms (including those terms, if
          any, providing for accelerated vesting) of the Company's
          1988 Incentive Stock Option Plan (the "1988 Incentive
          Plan"), the Company's 1988 Stock Option Plan for Outside
          Directors (the "1988 Option Plan"), the Company's 1993
          Incentive Stock Option Plan (the "Incentive Plan") and
          the Company's 1993 Stock Option Plan for Outside
          Directors (the "Option Plan" and together with the 1988
          Incentive Plan, the 1988 Option Plan and the Incentive
          Plan, the "Company Plans"):

                         (1)  The number of shares of Buyer
               Common Stock to be subject to the new option
               shall be equal to the product of the number of
               shares of Company Common Stock subject to the
               original option and the Exchange Ratio,
               provided that any fractional shares of Buyer
               Common Stock resulting from such multiplication
               shall be rounded down to the nearest share; and

                         (2)  The exercise price per share of
               Buyer Common Stock under the new option shall
               be equal to the exercise price per share of
               Company Common Stock under the original option
               divided by the Exchange Ratio, provided that
               such exercise price shall be rounded up to the
               nearest cent.

          The adjustment provided herein with respect to any
          options which are "incentive stock options" (as defined
          in Section 422 of the Internal Revenue Code of 1986, as
          amended (the "Code")) shall be and is intended to be
          effected in a manner which is consistent with Section
          424(a) of the Code.  The duration and other terms of the
          new option shall be the same as the original option,
          except that all references to the Company shall be deemed
          to be references to Buyer.  Notwithstanding anything to
          the contrary contained herein, all Limited Rights (as
          such term is defined in the 1988 Incentive Plan or the
          Incentive Plan, as the case may be) granted under the
          1988 Incentive Plan or the Incentive Plan shall terminate
          and be of no further force or effect upon receipt of
          consent to such termination from the grantees of such
          Limited Rights.  The Company will use its best efforts to
          obtain such consents from all holders of Limited Rights.

                    (b)  Without limiting the foregoing, and
          provided that the right contained in this paragraph (b)
          is not inconsistent with any of the conditions contained
          in Article VII hereof, each holder of a Company Option
          shall have the right (which right shall be exercised at
          least 5 days prior to the Closing Date by written notice
          to Buyer) to elect, in lieu of the provisions of Section
          1.5(a), to convert, at the Effective Time, all or a
          portion of his or her Company Options which have not
          expired prior to the Effective Time into the right to
          receive such number of shares (rounded to the nearest
          whole share) of Buyer Common Stock as are equal in value
          (determined by valuing each share of Buyer Common Stock
          at the Average Closing Price (as defined in Section 1.4))
          to the excess of (i) the product of the number of shares
          of Company Common Stock subject to such option, the
          Exchange Ratio and the Average Closing Price of the Buyer
          Common Stock over (ii) the aggregate exercise price of
          such option.

                    1.6.  Buyer Common Stock.  Except for shares of
          Buyer Common Stock owned by the Company or any of its
          Subsidiaries (other than Trust Account Shares and DPC
          Shares), which shall be converted into treasury stock of
          Buyer as contemplated by Section 1.4 hereof, the shares
          of Buyer Common Stock issued and outstanding immediately
          prior to the Effective Time shall be unaffected by the
          Merger and at the Effective Time, such shares shall
          remain issued and outstanding.

                    1.7.  Certificate of Incorporation.  At the
          Effective Time, the Certificate of Incorporation of
          Buyer, as in effect at the Effective Time, shall be the
          Certificate of Incorporation of the Surviving
          Corporation.

                    1.8.  By-Laws.  At the Effective Time, the By-
          Laws of Buyer, as in effect immediately prior to the
          Effective Time, shall be the By-Laws of the Surviving
          Corporation until thereafter amended in accordance with
          applicable law.

                    1.9.  Directors and Officers.  Except as
          provided in Section 6.14 hereof, the directors and
          officers of Buyer immediately prior to the Effective Time
          shall be the directors and officers of the Surviving
          Corporation, each to hold office in accordance with the
          Certificate of Incorporation and By-Laws of the Surviving
          Corporation until their respective successors are duly
          elected or appointed and qualified.

                    1.10.  Tax Consequences.  It is intended that
          the Merger and the Subsidiary Merger each constitute a
          reorganization within the meaning of Section 368(a) of
          the Code, and that this Agreement shall constitute a
          "plan of reorganization" for the purposes of Section 368
          of the Code. 

                                  ARTICLE II

                              EXCHANGE OF SHARES

                    2.1.  Buyer to Make Shares Available.  At or
          prior to the Effective Time, Buyer shall deposit, or
          shall cause to be deposited, with a bank or trust company
          (which may be a Subsidiary of Buyer) (the "Exchange
          Agent"), selected by Buyer and reasonably satisfactory to
          the Company, for the benefit of the holders of
          Certificates, for exchange in accordance with this
          Article II, certificates representing the shares of Buyer
          Common Stock and the cash in lieu of fractional shares
          (such cash and certificates for shares of Buyer Common
          Stock, together with any dividends or distributions with
          respect thereto, being hereinafter referred to as the
          "Exchange Fund") to be issued pursuant to Section 1.4 and
          paid pursuant to Section 2.2(a) in exchange for
          outstanding shares of Company Common Stock.

                    2.2.  Exchange of Shares.  (a)  As soon as
          practicable after the Effective Time, and in no event
          more than three business days thereafter, the Exchange
          Agent shall mail to each holder of record of a
          Certificate or Certificates a form letter of transmittal
          (which shall specify that delivery shall be effected, and
          risk of loss and title to the Certificates shall pass,
          only upon delivery of the Certificates to the Exchange
          Agent) and instructions for use in effecting the
          surrender of the Certificates in exchange for
          certificates representing the shares of Buyer Common
          Stock and the cash in lieu of fractional shares into
          which the shares of Company Common Stock represented by
          such Certificate or Certificates shall have been
          converted pursuant to this Agreement.  The Company shall
          have the right to review both the letter of transmittal
          and the instructions prior to the Effective Time and
          provide reasonable comments thereon.  Upon surrender of a
          Certificate for exchange and cancellation to the Exchange
          Agent, together with such letter of transmittal, duly
          executed, the holder of such Certificate shall be
          entitled to receive in exchange therefor (x) a
          certificate representing that number of whole shares of
          Buyer Common Stock to which such holder of Company Common
          Stock shall have become entitled pursuant to the
          provisions of Article I hereof and (y) a check
          representing the amount of cash in lieu of fractional
          shares, if any, which such holder has the right to
          receive in respect of the Certificate surrendered
          pursuant to the provisions of this Article II, and the
          Certificate so surrendered shall forthwith be cancelled. 
          No interest will be paid or accrued on the cash in lieu
          of fractional shares and unpaid dividends and
          distributions, if any, payable to holders of
          Certificates.  

                         (b)  No dividends or other distributions
          declared after the Effective Time with respect to Buyer
          Common Stock and payable to the holders of record thereof
          shall be paid to the holder of any unsurrendered
          Certificate until the holder thereof shall surrender such
          Certificate in accordance with this Article II.  After
          the surrender of a Certificate in accordance with this
          Article II, the record holder thereof shall be entitled
          to receive any such dividends or other distributions,
          without any interest thereon, which theretofore had
          become payable with respect to shares of Buyer Common
          Stock represented by such Certificate.  No holder of an
          unsurrendered Certificate shall be entitled, until the
          surrender of such Certificate, to vote the shares of
          Buyer Common Stock into which his Company Common Stock
          shall have been converted.

                         (c)  If any certificate representing
          shares of Buyer Common Stock is to be issued in a name
          other than that in which the Certificate surrendered in
          exchange therefor is registered, it shall be a condition
          of the issuance thereof that the Certificate so
          surrendered shall be properly endorsed (or accompanied by
          an appropriate instrument of transfer) and otherwise in
          proper form for transfer, and that the person requesting
          such exchange shall pay to the Exchange Agent in advance
          any transfer or other taxes required by reason of the
          issuance of a certificate representing shares of Buyer
          Common Stock in any name other than that of the
          registered holder of the Certificate surrendered, or
          required for any other reason, or shall establish to the
          satisfaction of the Exchange Agent that such tax has been
          paid or is not payable.

                         (d)  After the Effective Time, there shall
          be no transfers on the stock transfer books of the
          Company of the shares of Company Common Stock which were
          issued and outstanding immediately prior to the Effective
          Time.  If, after the Effective Time, Certificates
          representing such shares are presented for transfer to
          the Exchange Agent, they shall be cancelled and exchanged
          for certificates representing shares of Buyer Common
          Stock as provided in this Article II.

                         (e)  Notwithstanding anything to the
          contrary contained herein, no certificates or scrip
          representing fractional shares of Buyer Common Stock
          shall be issued upon the surrender for exchange of
          Certificates, no dividend or distribution with respect to
          Buyer Common Stock shall be payable on or with respect to
          any fractional share, and such fractional share interests
          shall not entitle the owner thereof to vote or to any
          other rights of a shareholder of Buyer.  In lieu of the
          issuance of any such fractional share, Buyer shall pay to
          each former stockholder of the Company who otherwise
          would be entitled to receive a fractional share of Buyer
          Common Stock an amount in cash determined by multiplying
          (i) the average of the closing sale prices of Buyer
          Common Stock on the New York Stock Exchange as reported
          by The Wall Street Journal for the five trading days
          immediately preceding the date on which the Effective
          Time shall occur by (ii) the fraction of a share of Buyer
          Common Stock to which such holder would otherwise be
          entitled to receive pursuant to Section 1.4 hereof.

                         (f)  Any portion of the Exchange Fund that
          remains unclaimed by the stockholders of the Company for
          six months after the Effective Time shall be paid to
          Buyer.  Any stockholders of the Company who have not
          theretofore complied with this Article II shall
          thereafter look only to Buyer for payment of their shares
          of Buyer Common Stock, cash in lieu of fractional shares
          and unpaid dividends and distributions on the Buyer
          Common Stock deliverable in respect of each share of
          Company Common Stock such stockholder holds as determined
          pursuant to this Agreement, in each case, without any
          interest thereon.  Notwithstanding the foregoing, none of
          Buyer, the Company, the Exchange Agent or any other
          person shall be liable to any former holder of shares of
          Company Common Stock for any amount properly delivered to
          a public official pursuant to applicable abandoned
          property, escheat or similar laws.

                         (g)  In the event any Certificate shall
          have been lost, stolen or destroyed, upon the making of
          an affidavit of that fact by the person claiming such
          Certificate to be lost, stolen or destroyed and, if
          required by Buyer, the posting by such person of a bond
          in such amount as Buyer may direct as indemnity against
          any claim that may be made against it with respect to
          such Certificate, the Exchange Agent will issue in
          exchange for such lost, stolen or destroyed Certificate
          the shares of Buyer Common Stock and cash in lieu of
          fractional shares deliverable in respect thereof pursuant
          to this Agreement.

                                 ARTICLE III

                REPRESENTATIONS AND WARRANTIES OF THE COMPANY

                    The Company hereby represents and warrants to

          Buyer as follows:

                    3.1.  Corporate Organization.  (a)  The Company
          is a corporation duly organized, validly existing and in
          good standing under the laws of the State of Delaware. 
          The Company has the corporate power and authority to own
          or lease all of its properties and assets and to carry on
          its business as it is now being conducted, and is duly
          licensed or qualified to do business in each jurisdiction
          in which the nature of the business conducted by it or
          the character or location of the properties and assets
          owned or leased by it makes such licensing or
          qualification necessary, except where the failure to be
          so licensed or qualified would not have a Material
          Adverse Effect (as defined below) on the Company.  The
          Company is duly registered as a unitary savings and loan
          holding company under the Home Owners' Loan Act of 1933,
          as amended.  The Certificate of Incorporation and By-laws
          of the Company, copies of which have previously been
          delivered to Buyer, are true, complete and correct copies
          of such documents as in effect as of the date of this
          Agreement.  As used in this Agreement, the term "Material
          Adverse Effect" means, with respect to Buyer, the Company
          or the Surviving Corporation, as the case may be, a
          material adverse effect on the business, properties,
          assets, liabilities, results of operations or financial
          condition of such party and its Subsidiaries taken as a
          whole, other than any such effect attributable to or
          resulting from general political or economic conditions
          or a change in law, rule, regulation, GAAP (as defined
          below) or regulatory accounting principles, which in each
          case affects banking institutions or their holding
          companies generally, except to the extent any such
          condition or change affects the referenced party to a
          materially greater extent than banking institutions or
          their holding companies generally.  As used in this
          Agreement, the word "Subsidiary" when used with respect
          to any party means any corporation, partnership or other
          organization, whether incorporated or unincorporated,
          which is consolidated with such party for financial
          reporting purposes. 

                         (b)  The Company Bank is a savings bank
          duly organized, validly existing and in good standing
          under the laws of the United States of America.  The
          deposit accounts of the Company Bank are insured by the
          Federal Deposit Insurance Corporation (the "FDIC")
          through the Savings Association Insurance Fund to the
          fullest extent permitted by law, and all premiums and
          assessments required to be paid in connection therewith
          have been paid when due by the Company Bank.  Each of the
          Company's other Subsidiaries is a corporation duly
          organized, validly existing and in good standing under
          the laws of its jurisdiction of incorporation or
          organization.  Each of the Company's Subsidiaries has the
          corporate power and authority to own or lease all of its
          properties and assets and to carry on its business as it
          is now being conducted and is duly licensed or qualified
          to do business in each jurisdiction in which the nature
          of the business conducted by it or the character or the
          location of the properties and assets owned or leased by
          it makes such licensing or qualification necessary,
          except where the failure to be so licensed or qualified
          would not have a Material Adverse Effect on the Company. 
          The articles of incorporation, by-laws and similar
          governing documents of each Subsidiary of the Company,
          copies of which have previously been delivered to Buyer,
          are true, complete and correct copies of such documents
          as in effect as of the date of this Agreement.

                         (c)  The minute books of the Company and
          each of its Subsidiaries contain true, complete and
          accurate records in all material respects of all meetings
          and other corporate actions held or taken since December
          31, 1991 of their respective stockholders and Boards of
          Directors (including committees of their respective
          Boards of Directors).

                    3.2.  Capitalization.  (a) The authorized
          capital stock of the Company consists of 8,900,000 shares
          of Company Common Stock and 5,000,000 shares of preferred
          stock, par value $.01 per share (the "Company Preferred
          Stock").  As of the date of this Agreement, there are (x)
          5,076,504 shares of Company Common Stock issued and
          outstanding and 236,474 shares of Company Common Stock
          held in the Company's treasury, (y) no shares of Company
          Common Stock reserved for issuance upon exercise of
          outstanding stock options or otherwise except for (i)
          511,909 shares of Company Common Stock reserved for
          issuance pursuant to the Company Option Plans and
          described in Section 3.2(a) of the Disclosure Schedule
          which is being delivered to Buyer concurrently herewith
          (the "Company Disclosure Schedule") and (ii) 557,795
          shares of Company Common Stock reserved for issuance upon
          exercise of the option issued to Buyer pursuant to the
          Stock Option Agreement, dated June 27, 1994, between
          Buyer and the Company (the "Option Agreement") and (z) no
          shares of Company Preferred Stock issued or outstanding,
          held in the Company's treasury or reserved for issuance
          upon exercise of outstanding stock options or otherwise. 
          All of the issued and outstanding shares of Company
          Common Stock have been duly authorized and validly issued
          and are fully paid, nonassessable and free of preemptive
          rights, with no personal liability attaching to the
          ownership thereof.  Except as referred to above or
          reflected in Section 3.2(a) of the Company Disclosure
          Schedule, and except for the Option Agreement, the
          Company does not have and is not bound by any outstanding
          subscriptions, options, warrants, calls, commitments or
          agreements of any character calling for the purchase or
          issuance of any shares of Company Common Stock or Company
          Preferred Stock or any other equity security of the
          Company or any securities representing the right to
          purchase or otherwise receive any shares of Company
          Common Stock or any other equity security of the Company. 
          The names of the optionees, the date of each option to
          purchase Company Common Stock granted, the number of
          shares subject to each such option, the number of Limited
          Rights attached to such number of shares, the expiration
          date of each such option, and the price at which each
          such option may be exercised under the Option Plan, the
          Incentive Plan, the 1988 Option Plan or the 1988
          Incentive Plan, as applicable, are set forth in Section
          3.2(a) of the Company Disclosure Schedule.

                         (b)  Section 3.2(b) of the Company
          Disclosure Schedule sets forth a true and correct list of
          all of the Subsidiaries of the Company as of the date of
          this Agreement.  Except as set forth in Section 3.2(b) of
          the Company Disclosure Schedule, the Company owns,
          directly or indirectly, all of the issued and outstanding
          shares of the capital stock of each of such Subsidiaries,
          free and clear of all liens, charges, encumbrances and
          security interests whatsoever, and all of such shares are
          duly authorized and validly issued and are fully paid,
          nonassessable and free of preemptive rights, with no
          personal liability attaching to the ownership thereof. 
          No Subsidiary of the Company has or is bound by any
          outstanding subscriptions, options, warrants, calls,
          commitments or agreements of any character calling for
          the purchase or issuance of any shares of capital stock
          or any other equity security of such Subsidiary or any
          securities representing the right to purchase or
          otherwise receive any shares of capital stock or any
          other equity security of such Subsidiary.  Assuming
          compliance by Buyer with Section 1.5 hereof, at the
          Effective Time, there will not be any outstanding
          subscriptions, options, warrants, calls, commitments or
          agreements of any character by which the Company or any
          of its Subsidiaries will be bound calling for the
          purchase or issuance of any shares of the capital stock
          of the Company or any of its Subsidiaries.

                    3.3.  Authority; No Violation.  (a)  The
          Company has full corporate power and authority to execute
          and deliver this Agreement and to consummate the
          transactions contemplated hereby.  The execution and
          delivery of this Agreement and the consummation of the
          transactions contemplated hereby have been duly and
          validly approved by the Board of Directors of the
          Company.  The Board of Directors of the Company has
          directed that this Agreement and the transactions
          contemplated hereby be submitted to the Company's
          stockholders for approval at a meeting of such
          stockholders and, except for the adoption of this
          Agreement by the requisite vote of the Company's
          stockholders, no other corporate proceedings on the part
          of the Company are necessary to approve this Agreement
          and to consummate the transactions contemplated hereby. 
          This Agreement has been duly and validly executed and
          delivered by the Company and (assuming due authorization,
          execution and delivery by Buyer) constitutes a valid and
          binding obligation of the Company, enforceable against
          the Company in accordance with its terms, except as
          enforcement may be limited by general principles of
          equity whether applied in a court of law or a court of
          equity and by bankruptcy, insolvency and similar laws
          affecting creditors' rights and remedies generally.

                         (b)  The Company Bank has full corporate
          power and authority to execute and deliver the Bank
          Merger Agreement and to consummate the transactions
          contemplated thereby.  The execution and delivery of the
          Bank Merger Agreement and the consummation of the
          transactions contemplated thereby will be duly and
          validly approved by the Board of Directors of the Company
          Bank.  Upon the due and valid approval of the Bank Merger
          Agreement by the Company as the sole stockholder of the
          Company Bank and by the Board of Directors of the Company
          Bank, no other corporate proceedings on the part of the
          Company Bank will be necessary to consummate the
          transactions contemplated thereby.  The Bank Merger
          Agreement, upon execution and delivery by the Company
          Bank, will be duly and validly executed and delivered by
          the Company Bank and will (assuming due authorization,
          execution and delivery by New York Bank) constitute a
          valid and binding obligation of the Company Bank,
          enforceable against the Company Bank in accordance with
          its terms, except as enforcement may be limited by
          general principles of equity whether applied in a court
          of law or a court of equity and by bankruptcy, insolvency
          and similar laws affecting creditors' rights and remedies
          generally.

                         (c)  Except as set forth in Section 3.3(c)
          of the Company Disclosure Schedule, neither the execution
          and delivery of this Agreement by the Company or the Bank
          Merger Agreement by the Company Bank, nor the
          consummation by the Company or the Company Bank, as the
          case may be, of the transactions contemplated hereby or
          thereby, nor compliance by the Company or the Company
          Bank, as the case may be, with any of the terms or
          provisions hereof or thereof, will (i) violate any
          provision of the Certificate of Incorporation or By-Laws
          of the Company or the certificate of incorporation, by-
          laws or similar governing documents of any of its
          Subsidiaries, or (ii) assuming that the consents and
          approvals referred to in Section 3.4 hereof are duly
          obtained, (x) violate any statute, code, ordinance, rule,
          regulation, judgment, order, writ, decree or injunction
          applicable to the Company or any of its Subsidiaries, or
          any of their respective properties or assets, or (y)
          violate, conflict with, result in a breach of any
          provision of or the loss of any benefit under, constitute
          a default (or an event which, with notice or lapse of
          time, or both, would constitute a default) under, result
          in the termination of or a right of termination or
          cancellation under, accelerate the performance required
          by, or result in the creation of any lien, pledge,
          security interest, charge or other encumbrance upon any
          of the respective properties or assets of the Company or
          any of its Subsidiaries under, any of the terms,
          conditions or provisions of any note, bond, mortgage,
          indenture, deed of trust, license, lease, agreement or
          other instrument or obligation to which the Company or
          any of its Subsidiaries is a party, or by which they or
          any of their respective properties or assets may be bound
          or affected, except (in the case of clause (y) above) for
          such violations, conflicts, breaches or defaults which,
          either individually or in the aggregate, would not have
          or be reasonably likely to have a Material Adverse Effect
          on the Company.

                    3.4.  Consents and Approvals.  Except for (a)
          the filing of applications and notices, as applicable,
          with the Board of Governors of the Federal Reserve System
          (the "Federal Reserve Board") under the Oakar Amendment
          to the Federal Deposit Insurance Act and the Bank Holding
          Company Act of 1956, as amended (the "BHC Act") and
          approval of such applications and notices, (b) the filing
          of applications with the FDIC under the Bank Merger Act
          and approval of such applications, (c) the filing of
          applications with the Office of Thrift Supervision (the
          "OTS") and approval of such applications, (d) the filing
          of an application with the New York State Banking
          Department (the "Banking Department"), which filing shall
          include, if Buyer so requests pursuant to Section 6.13
          hereof, an application for conversion of the Company Bank
          from a federally chartered stock savings bank to a New
          York chartered stock savings bank (the "State Banking
          Approval"), (e) the filing with the Securities and
          Exchange Commission (the "SEC") of a joint proxy
          statement in definitive form relating to the meetings of
          the Company's stockholders and Buyer's stockholders to be
          held in connection with this Agreement and the
          transactions contemplated hereby (the "Proxy Statement"),
          (f) the approval of this Agreement by the requisite vote
          of the stockholders of the Company, (g) the filing of the
          Certificate of Merger with the Secretary pursuant to the
          DGCL, (h) the filings required by the Bank Merger
          Agreement, (i) the approval of the Bank Merger Agreement
          by the Company as the sole stockholder of the Company
          Bank and (j) such filings, authorizations or approvals as
          may be set forth in Section 3.4 of the Company Disclosure
          Schedule, no consents or approvals of or filings or
          registrations with any court, administrative agency or
          commission or other governmental authority or
          instrumentality (each a "Governmental Entity") or with
          any third party are necessary in connection with (1) the
          execution and delivery by the Company of this Agreement,
          (2) the consummation by the Company of the Merger and the
          other transactions contemplated hereby, (3) the execution
          and delivery by the Company Bank of the Bank Merger
          Agreement, and (4) the consummation by the Company Bank
          of the Subsidiary Merger and the transactions
          contemplated thereby.

                    3.5.  Reports.  The Company and each of its
          Subsidiaries have timely filed all material reports,
          registrations and statements, together with any
          amendments required to be made with respect thereto, that
          they were required to file since December 31, 1991 with
          (i) the OTS, (ii) the FDIC, (iii) any state banking
          commissions or any other state regulatory authority (each
          a "State Regulator") and (iv) any other self-regulatory
          organization ("SRO") (collectively with the Federal
          Reserve Board, the "Regulatory Agencies"), and all other
          material reports and statements required to be filed by
          them since December 31, 1991, including, without
          limitation, any report or statement required to be filed
          pursuant to the laws, rules or regulations of the United
          States, the OTS, the FDIC, any State Regulator or any
          SRO, and have paid all fees and assessments due and
          payable in connection therewith.  Except for normal
          examinations conducted by a Regulatory Agency in the
          regular course of the business of the Company and its
          Subsidiaries, except as set forth in Section 3.5 of the
          Company Disclosure Schedule, no Regulatory Agency has
          initiated any proceeding or, to the best knowledge of the
          Company, investigation into the business or operations of
          the Company or any of its Subsidiaries since December 31,
          1991.  There is no unresolved material violation,
          criticism, or exception by any Regulatory Agency with
          respect to any report or statement relating to any
          examinations of the Company or any of its Subsidiaries.

                    3.6.  Financial Statements.  The Company has
          previously delivered to Buyer copies of (a) the
          consolidated balance sheets of the Company and its
          Subsidiaries as of September 30 for the fiscal years 1992
          and 1993, and the related consolidated statements of
          income, changes in stockholders' equity and cash flows
          for the fiscal years 1991 through 1993, inclusive, as
          reported in the Company's Annual Report on Form 10-K for
          the fiscal year ended September 30, 1993 filed with the
          SEC under the Securities Exchange Act of 1934, as amended
          (the "Exchange Act"), in each case accompanied by the
          audit report of KPMG Peat Marwick, independent public
          accountants with respect to the Company, and (b) the
          unaudited consolidated balance sheets of the Company and
          its Subsidiaries as of March 31, 1994 and March 31, 1993
          and the related unaudited consolidated statements of
          income, cash flows and changes in stockholders' equity
          for the six month periods then ended as reported in the
          Company's Quarterly Report on Form 10-Q for the period
          ended March 31, 1994 filed with the SEC under the
          Exchange Act.  The September 30, 1993 consolidated
          balance sheet of the Company (including the related
          notes, where applicable) fairly presents the consolidated
          financial position of the Company and its Subsidiaries as
          of the date thereof, and the other financial statements
          referred to in this Section 3.6 (including the related
          notes, where applicable) fairly present, and the
          financial statements referred to in Section 6.9 hereof
          will fairly present (subject, in the case of the
          unaudited statements, to recurring audit adjustments
          normal in nature and amount), the results of the
          consolidated operations and consolidated financial
          position of the Company and its Subsidiaries for the
          respective fiscal periods or as of the respective dates
          therein set forth; each of such statements (including the
          related notes, where applicable) comply, and the
          financial statements referred to in Section 6.9 hereof
          will comply, in all material respects with applicable
          accounting requirements and with the published rules and
          regulations of the SEC with respect thereto; and each of
          such statements (including the related notes, where
          applicable) has been, and the financial statements
          referred to in Section 6.9 hereof will be, prepared in
          accordance with generally accepted accounting principles
          ("GAAP") consistently applied during the periods
          involved, except as indicated in the notes thereto or, in
          the case of unaudited statements, as permitted by Form
          10-Q.  The books and records of the Company and its
          Subsidiaries have been, and are being, maintained in all
          material respects in accordance with GAAP and any other
          applicable legal and accounting requirements and reflect
          only actual transactions.

                    3.7.  Broker's Fees.  Neither the Company nor
          any Subsidiary of the Company nor any of their respective
          officers or directors has employed any broker or finder
          or incurred any liability for any broker's fees,
          commissions or finder's fees in connection with any of
          the transactions contemplated by this Agreement, the Bank
          Merger Agreement or the Option Agreement, except that the
          Company has engaged, and will pay a fee or commission to,
          Keefe, Bruyette & Woods, Inc. ("Keefe, Bruyette") in
          accordance with the terms of a letter agreement between
          Keefe, Bruyette and the Company, a true, complete and
          correct copy of which has been previously delivered by
          the Company to Buyer.

                    3.8.  Absence of Certain Changes or Events. 
          (a)  Except as may be set forth in Section 3.8(a) of the
          Company Disclosure Schedule or as disclosed in the
          Company's Quarterly Report on Form 10-Q for the quarter
          ended March 31, 1994 (a true, complete and correct copy
          of which has previously been delivered to Buyer), since
          September 30, 1993, (i) neither the Company nor any of
          its Subsidiaries has incurred any material liability,
          except in the ordinary course of their business
          consistent with their past practices, and (ii) no event
          has occurred which has caused, or is reasonably likely to
          cause, individually or in the aggregate, a Material
          Adverse Effect on the Company.

                         (b)  Except as set forth in Section 3.8(b)
          of the Company Disclosure Schedule, since March 31, 1994,
          the Company and its Subsidiaries have carried on their
          respective businesses in the ordinary course consistent
          with their past practices. 

                         (c)  Except as set forth in Section 3.8(c)
          of the Company Disclosure Schedule, since March 31, 1994,
          neither the Company nor any of its Subsidiaries has (i)
          increased the wages, salaries, compensation, pension, or
          other fringe benefits or perquisites payable to any
          executive officer, employee, or director from the amount
          thereof in effect as of March 31, 1994 (which amounts
          have been previously disclosed to Buyer), granted any
          severance or termination pay, entered into any contract
          to make or grant any severance or termination pay, or
          paid any bonus other than year-end bonuses for fiscal
          1993 as listed in Section 3.8 of the Company Disclosure
          Schedule or (ii) suffered any strike, work stoppage,
          slow-down, or other labor disturbance.

                    3.9.  Legal Proceedings.  (a)  Except as set
          forth in Section 3.9 of the Company Disclosure Schedule,
          neither the Company nor any of its Subsidiaries is a
          party to any, and there are no pending or, to the best of
          the Company's knowledge, threatened, legal,
          administrative, arbitral or other proceedings, claims,
          actions or governmental or regulatory investigations of
          any nature against the Company or any of its Subsidiaries
          or challenging the validity or propriety of the
          transactions contemplated by this Agreement, the Bank
          Merger Agreement or the Option Agreement as to which
          there is a reasonable probability of an adverse
          determination and which, if adversely determined, would,
          individually or in the aggregate, have or be reasonably
          likely to have a Material Adverse Effect on the Company.

                         (b)  There is no injunction, order,
          judgment, decree, or regulatory restriction imposed upon
          the Company, any of its Subsidiaries or the assets of the
          Company or any of its Subsidiaries which has had, or
          could reasonably be expected to have, a Material Adverse
          Effect on the Company.

                    3.10.  Taxes. (a)  Except as set forth in
          Section 3.10(a) of the Company Disclosure Schedule, each
          of the Company and its Subsidiaries has (i) duly and
          timely filed or will duly and timely file (including
          applicable extensions granted without penalty) all Tax
          Returns (as hereinafter defined) required to be filed at
          or prior to the Effective Time, and such Tax Returns
          which have heretofore been filed are, and those to be
          hereinafter filed will be, true, correct and complete and
          (ii) paid in full or have made adequate provision for on
          the financial statements of the Company (in accordance
          with GAAP) all Taxes (as hereinafter defined) and will
          pay in full or make adequate provision for all Taxes. 
          There are no material liens for Taxes upon the assets of
          either the Company or its Subsidiaries except for
          statutory liens for current Taxes not yet due.  Except as
          set forth in Section 3.10(a) of the Company Disclosure
          Schedule, neither the Company nor any of its Subsidiaries
          has requested any extension of time within which to file
          any Tax Returns in respect of any fiscal year which have
          not since been filed and no request for waivers of the
          time to assess any Taxes are pending or outstanding.  The
          federal and state income Tax Returns of the Company and
          its Subsidiaries have been audited by the Internal
          Revenue Service or appropriate state tax authorities with
          respect to those periods and jurisdictions set forth on
          Section 3.10(a) of the Company Disclosure Schedule. 
          Except as set forth in Section 3.10(a) of the Company
          Disclosure Schedule, neither the Company nor any of its
          Subsidiaries (i) is a party to any agreement providing
          for the allocation or sharing of Taxes (other than the
          allocation of federal income taxes as provided by
          Regulation 1.1552-1(a)(1) under the Code; (ii) is
          required to include in income any adjustment pursuant to
          Section 481(a) of the Code, by reason of the voluntary
          change in accounting method (nor has any taxing authority
          proposed in writing any such adjustment or change of
          accounting method); or (iii) has filed a consent pursuant
          to Section 341(f) of the Code.

                    (b)  Except as set forth in Section 3.10(b) of
          the Company Disclosure Schedule, neither the Company nor
          any of its Subsidiaries owns, directly or indirectly
          (including, without limitation, through partnerships,
          corporations, trusts or other entities), interests in
          real property ("Real Property Interests") situated in (A)
          New York State, which by reason of the Merger or
          Subsidiary Merger would be subject to either (i) the New
          York State Real Property Gains Tax, (ii) the New York
          State Real Property Transfer Tax, or (iii) the New York
          City Real Property Transfer Tax (collectively, the "New
          York Transfer Taxes"), or (B) any state other than New
          York State which by reason of the Merger or Subsidiary
          Merger would be subject to any tax similar to the New
          York Transfer Taxes.  For purposes of this Section
          3.10(b), Real Property Interests include, without
          limitation, titles in fee, leasehold interests,
          beneficial interests, encumbrances, developments rights
          or any other interests with the right to use or occupy
          real property or the right to receive rents, profits or
          other income derived therefrom, or any options or
          contracts to purchase real property.

                      For the purposes of this Agreement, "Taxes"
          shall mean all taxes, charges, fees, levies, penalties or
          other assessments imposed by any United States federal,
          state, local or foreign taxing authority, including, but
          not limited to income, excise, property, sales, transfer,
          franchise, payroll, withholding, social security or other
          taxes, including any interest, penalties or additions
          attributable thereto.

                      For purposes of this Agreement, "Tax Return"
          shall mean any return, report, information return or
          other document (including any related or supporting
          information) with respect to Taxes.

                    3.11.  Employees.  (a)  Section 3.11(a) of the
          Company Disclosure Schedule sets forth a true and
          complete list of each employee benefit plan, arrangement
          or agreement that is maintained or contributed to or
          required to be contributed to as of the date of this
          Agreement (the "Plans") by the Company, any of its
          Subsidiaries or by any trade or business, whether or not
          incorporated (an "ERISA Affiliate"), all of which
          together with the Company would be deemed a "single
          employer" within the meaning of Section 4001 of the
          Employee Retirement Income Security Act of 1974, as
          amended ("ERISA"), for the benefit of any employee or
          former employee of the Company, any Subsidiary or any
          ERISA Affiliate.

                         (b)  The Company has heretofore delivered
          to Buyer true and complete copies of each of the Plans
          and all related documents, including but not limited to
          (i) the actuarial report for such Plan (if applicable)
          for each of the last two years, and (ii) the most recent
          determination letter from the Internal Revenue Service
          (if applicable) for such Plan.

                         (c)  Except as set forth in Section
          3.11(c) of the Company Disclosure Schedule, (i) each of
          the Plans has been operated and administered in all
          material respects in accordance with its terms and
          applicable law, including but not limited to ERISA and
          the Code, (ii) each of the Plans intended to be
          "qualified" within the meaning of Section 401(a) of the
          Code either (1) has received a favorable determination
          letter from the IRS, or (2) is or will be the subject of
          an application for a favorable determination letter, and
          the Company is not aware of any circumstances likely to
          result in the revocation or denial of any such favorable
          determination letter, (iii) with respect to each Plan
          which is subject to Title IV of ERISA, the present value
          of accrued benefits under such Plan, based upon the
          actuarial assumptions used for funding purposes in the
          most recent actuarial report prepared by such Plan's
          actuary with respect to such Plan, did not, as of its
          latest valuation date, exceed the then current value of
          the assets of such Plan allocable to such accrued
          benefits, (iv) no Plan provides benefits, including
          without limitation death or medical benefits (whether or
          not insured), with respect to current or former employees
          of the Company, its Subsidiaries or any ERISA Affiliate
          beyond their retirement or other termination of service,
          other than (w) coverage mandated by applicable law, (x)
          death benefits or retirement benefits under any "employee
          pension plan," as that term is defined in Section 3(2) of
          ERISA, (y) deferred compensation benefits accrued as
          liabilities on the books of the Company, its Subsidiaries
          or the ERISA Affiliates or (z) benefits the full cost of
          which is borne by the current or former employee (or his
          beneficiary), (v) no liability under Title IV of ERISA
          has been incurred by the Company, its Subsidiaries or any
          ERISA Affiliate that has not been satisfied in full, and
          no condition exists that presents a material risk to the
          Company, its Subsidiaries or an ERISA Affiliate of
          incurring a material liability thereunder, (vi) no Plan
          is a "multiemployer pension plan," as such term is
          defined in Section 3(37) of ERISA, (vii) all
          contributions or other amounts payable by the Company,
          its Subsidiaries or any ERISA Affiliates as of the
          Effective Time with respect to each Plan in respect of
          current or prior plan years have been paid or accrued in
          accordance with generally accepted accounting practices
          and Section 412 of the Code, (viii) neither the Company,
          its Subsidiaries nor any ERISA Affiliate has engaged in a
          transaction in connection with which the Company, its
          Subsidiaries or any ERISA Affiliate could be subject to
          either a civil penalty assessed pursuant to Section 409
          or 502(i) of ERISA or a tax imposed pursuant to Section
          4975 or 4976 of the Code, (ix) there are no pending, or,
          to the best knowledge of the Company, threatened or
          anticipated claims (other than routine claims for
          benefits) by, on behalf of or against any of the Plans or
          any trusts related thereto and (x) the consummation of
          the transactions contemplated by this Agreement will not
          (y) entitle any current or former employee or officer of
          the Company or any ERISA Affiliate to severance pay,
          termination pay or any other payment, except as expressly
          provided in this Agreement or (z) accelerate the time of
          payment or vesting or increase the amount of compensation
          due any such employee or officer.

                    3.12.  SEC Reports.  The Company has previously
          made available to Buyer an accurate and complete copy of
          each (a) final registration statement, prospectus,
          report, schedule and definitive proxy statement filed
          since January 1, 1990 by the Company with the SEC
          pursuant to the Securities Act of 1933, as amended (the
          "Securities Act") or the Exchange Act (the "Company
          Reports") and (b) communication mailed by the Company to
          its stockholders since January 1, 1990, and no such
          registration statement, prospectus, report, schedule,
          proxy statement or communication contained any untrue
          statement of a material fact or omitted to state any
          material fact required to be stated therein or necessary
          in order to make the statements therein, in light of the
          circumstances in which they were made, not misleading,
          except that information as of a later date shall be
          deemed to modify information as of an earlier date.  The
          Company has timely filed all Company Reports and other
          documents required to be filed by it under the Securities
          Act and the Exchange Act, and, as of their respective
          dates, all Company Reports complied in all material
          respects with the published rules and regulations of the
          SEC with respect thereto.

                    3.13.  Company Information.  The information
          relating to the Company and its Subsidiaries to be
          contained in the Proxy Statement and the registration
          statement on Form S-4 (the "S-4") of which the Proxy
          Statement will be included as a prospectus, or in any
          other document filed with any other regulatory agency in
          connection herewith, will not contain any untrue
          statement of a material fact or omit to state a material
          fact necessary to make the statements therein, in light
          of the circumstances in which they are made, not
          misleading.  The Proxy Statement (except for such
          portions thereof that relate only to Buyer or any of its
          Subsidiaries) will comply in all material respects with
          the provisions of the Exchange Act and the rules and
          regulations thereunder.

                    3.14.  Compliance with Applicable Law.  The
          Company and each of its Subsidiaries hold, and have at
          all times held, all material licenses, franchises,
          permits and authorizations necessary for the lawful
          conduct of their respective businesses under and pursuant
          to all, and have complied with and are not in default in
          any respect under any, applicable law, statute, order,
          rule, regulation, policy and/or guideline of any
          Governmental Entity relating to the Company or any of its
          Subsidiaries, except where the failure to hold such
          license, franchise, permit or authorization or such
          noncompliance or default would not, individually or in
          the aggregate, have or be reasonably likely to have a
          Material Adverse Effect on the Company, and neither the
          Company nor any of its Subsidiaries knows of, or has
          received notice of, any material violations of any of the
          above.

                    3.15.  Certain Contracts.  (a)  Except as set
          forth in Section 3.15(a) of the Company Disclosure
          Schedule, neither the Company nor any of its Subsidiaries
          is a party to or bound by any contract, arrangement,
          commitment or understanding (whether written or oral) (i)
          with respect to the employment of any directors,
          officers, employees or consultants, (ii) which, upon the
          consummation of the transactions contemplated by this
          Agreement or the Bank Merger Agreement will (either alone
          or upon the occurrence of any additional acts or events)
          result in any payment (whether of severance pay or
          otherwise) becoming due from Buyer, the Company, the
          Surviving Corporation, the Surviving Bank or any of their
          respective Subsidiaries to any officer or employee
          thereof, (iii) which is a material contract (as defined
          in Item 601(b)(10) of Regulation S-K of the SEC) to be
          performed after the date of this Agreement that has not
          been filed or incorporated by reference in the Company
          Reports, (iv) which is a consulting agreement (including
          data processing, software programming and licensing
          contracts) not terminable on 60 days or less notice
          involving the payment of more than $100,000 per annum, in
          the case of any such agreement with an individual, or
          $500,000 per annum, in the case of any other such
          agreement, (v) which materially restricts the conduct of
          any line of business by the Company or any of its
          Subsidiaries, (vi) with or to a labor union or guild
          (including any collective bargaining agreement) or (vii)
          (including any stock option plan, stock appreciation
          rights plan, restricted stock plan or stock purchase
          plan) any of the benefits of which will be increased, or
          the vesting of the benefits of which will be accelerated,
          by the occurrence of any of the transactions contemplated
          by this Agreement or the Bank Merger Agreement, or the
          value of any of the benefits of which will be calculated
          on the basis of any of the transactions contemplated by
          this Agreement or the Bank Merger Agreement.  Each
          contract, arrangement, commitment or understanding of the
          type described in this Section 3.15(a), whether or not
          set forth in Section 3.15(a) of the Company Disclosure
          Schedule, is referred to herein as a "Company Contract". 
          The Company has previously delivered to Buyer true and
          correct copies of each Company Contract.

                         (b)  Except as set forth in Section
          3.15(b) of the Company Disclosure Schedule, (i) each
          Company Contract is valid and binding and in full force
          and effect, (ii) the Company and each of its Subsidiaries
          have in all material respects performed all obligations
          required to be performed by it to date under each Company
          Contract, except where such noncompliance, individually
          or in the aggregate, would not have or be reasonably
          likely to have a Material Adverse Effect on the Company,
          (iii) no event or condition exists which constitutes or,
          after notice or lapse of time or both, would constitute,
          a material default on the part of the Company or any of
          its Subsidiaries under any such Company Contract, except
          where such default, individually or in the aggregate,
          would not have or be reasonably likely to have a Material
          Adverse Effect on the Company and (iv) no other party to
          such Company Contract is, to the best knowledge of the
          Company, in default in any respect thereunder.

                    3.16.  Agreements with Regulatory Agencies. 
          Except as set forth in Section 3.16 of the Company
          Disclosure Schedule, neither the Company nor any of its
          Subsidiaries is subject to any cease-and-desist or other
          order issued by, or is a party to any written agreement,
          consent agreement or memorandum of understanding with, or
          is a party to any commitment letter or similar
          undertaking to, or is subject to any order or directive
          by, or is a recipient of any extraordinary supervisory
          letter from, or has adopted any board resolutions at the
          request of (each, whether or not set forth on Section
          3.16 of the Company Disclosure Schedule, a "Regulatory
          Agreement"), any Regulatory Agency or other Governmental
          Entity that restricts the conduct of its business or that
          in any manner relates to its capital adequacy, its credit
          policies, its management or its business, nor has the
          Company or any of its Subsidiaries been advised by any
          Regulatory Agency or other Governmental Entity that it is
          considering issuing or requesting any Regulatory
          Agreement. 

                    3.17.  Investment Securities.  Section 3.17 of
          the Company Disclosure Schedule sets forth the book and
          market value as of March 31, 1994 of the investment
          securities, mortgage backed securities and securities
          held for sale of the Company and its Subsidiaries. 
          Section 3.17 of the Company Disclosure Schedule sets
          forth an investment securities report which includes,
          security descriptions, CUSIP numbers, pool face values,
          book values, coupon rates and current market values.


                    3.18.  Intellectual Property.  Except where
          there would be no Material Adverse Effect on the Company,
          the Company and each of its Subsidiaries owns or
          possesses valid and binding licenses and other rights to
          use without payment all material patents, copyrights,
          trade secrets, trade names, servicemarks and trademarks
          used in its businesses; and neither the Company nor any
          of its Subsidiaries has received any notice of conflict
          with respect thereto that asserts the right of others. 
          The Company and each of its Subsidiaries have in all
          material respects performed all the obligations required
          to be performed by them and are not in default in any
          material respect under any contract, agreement,
          arrangement or commitment relating to any of the
          foregoing, except where such non-performance or default
          would not, individually or in the aggregate, have or be
          reasonably likely to have a Material Adverse Effect on
          the Company.

                    3.19.  Undisclosed Liabilities.  Except (a) as
          set forth in Section 3.19 of the Company Disclosure
          Schedule, (b) for those liabilities that are fully
          reflected or reserved against on the consolidated balance
          sheet of the Company as of March 31, 1994 included in its
          Form 10-Q for the period ended March 31, 1994 and (c) for
          liabilities incurred in the ordinary course of business
          consistent with past practice since March 31, 1994 that,
          either alone or when combined with all similar
          liabilities, have not had, and could not reasonably be
          expected to have, a Material Adverse Effect on the
          Company, neither the Company nor any of its Subsidiaries
          has incurred any liability of any nature whatsoever
          (whether absolute, accrued, contingent or otherwise and
          whether due or to become due).

                    3.20.  State Takeover Laws.  The provisions of
          Section 203 of the DGCL and Section 8 of the Company's
          Certificate of Incorporation will not, assuming the
          accuracy of the representations contained in Section 4.12
          hereof, apply to the Agreement, the Bank Merger Agreement
          or the Option Agreement or any of the transactions
          contemplated hereby or thereby.

                    3.21.  Administration of Fiduciary Accounts. 
          The Company and each of its Subsidiaries has properly
          administered in all material respects all accounts for
          which it acts as a fiduciary, including but not limited
          to accounts for which it serves as a trustee, agent,
          custodian, personal representative, guardian, conservator
          or investment advisor, in accordance with the terms of
          the governing documents and applicable state and federal
          law and regulation and common law.  Neither the Company
          nor any of its Subsidiaries nor any of their respective
          directors, officers or employees has committed any breach
          of trust with respect to any such fiduciary account which
          has had or could reasonably be expected to have a
          Material Adverse Effect on the Company, and the
          accountings for each such fiduciary account are true and
          correct in all material respects and accurately reflect
          the assets of such fiduciary account.

                    3.22.  Environmental Matters.  Except as set
          forth in Section 3.22 of the Company Disclosure Schedule:

                         (a)  Each of the Company, its
          Subsidiaries, the Participation Facilities and the Loan
          Properties (each as hereinafter defined) are, and have
          been, in compliance with all applicable federal, state
          and local laws including common law, regulations and
          ordinances and with all applicable decrees, orders and
          contractual obligations relating to pollution the
          discharge of, or exposure to materials in the environment
          or workplace ("Environmental Laws"), except for
          violations which, either individually or in the
          aggregate, have not had and cannot reasonably be expected
          to have a Material Adverse Effect on the Company;

                         (b)  There is no suit, claim, action or
          proceeding, pending or threatened, before any
          Governmental Entity or other forum in which the Company,
          any of its Subsidiaries, any Participation Facility or
          any Loan Property, has been or, with respect to
          threatened proceedings, may be, named as a defendant (x)
          for alleged noncompliance (including by any predecessor),
          with any Environmental Laws, or (y) relating to the
          release, threatened release or exposure to any material
          whether or not occurring at or on a site owned, leased or
          operated by the Company or any of its Subsidiaries, any
          Participation Facility or any Loan Property, except where
          such noncompliance or release has not resulted, and
          cannot be reasonably expected to result, either
          individually or in the aggregate, a Material Adverse
          Effect on the Company;

                         (c)  During the period of (x) the
          Company's or any of its Subsidiaries' ownership or
          operation of any of their respective current properties,
          (y) the Company's or any of its Subsidiaries'
          participation in the management of any Participation
          Facility, or (z) the Company's or any of its
          Subsidiaries' holding of a security interest in a Loan
          Property, there has been no release of materials in, on,
          under or affecting any such property, except where such
          release has not had and cannot reasonably be expected to
          result in, either individually or in the aggregate, a
          Material Adverse Effect on the Company.  Prior to the
          period of (x) the Company's or any of its Subsidiaries'
          ownership or operation of any of their respective current
          properties, (y) the Company's or any of its Subsidiaries'
          participation in the management of any Participation
          Facility, or (z) the Company's or any of its
          Subsidiaries' holding of a security interest in a Loan
          Property, there was no release or threatened release of
          materials in, on, under or affecting any such property,
          Participation Facility or Loan Property, except where
          such release has not had and cannot be reasonably
          expected to have, either individually or in the
          aggregate, a Material Adverse Effect on the Company; and 

                         (d)  The following definitions apply for
          purposes of this Section 3.22: (x) "Loan Property" means
          any property in which the Company or any of its
          Subsidiaries holds a security interest, and, where
          required by the context, said term means the owner or
          operator of such property; and (y) "Participation
          Facility" means any facility in which the Company or any
          of its Subsidiaries participates in the management and,
          where required by the context, said term means the owner
          or operator of such property.

                    3.23.  Derivative Transactions.  Except as set
          forth in Section 3.23 of the Company Disclosure Schedule,
          since September 30, 1993, neither Company nor any of its
          Subsidiaries has engaged in transactions in or involving
          forwards, futures, options on futures, swaps or other
          derivative instruments except (i) as agent on the order
          and for the account of others, or (ii) as principal for
          purposes of hedging interest rate risk on U.S. dollar-
          denominated securities and other financial instruments. 
          None of the counterparties to any contract or agreement
          with respect to any such instrument is in default with
          respect to such contract or agreement and no such
          contract or agreement, were it to be a Loan (as defined
          below) held by the Company or any of its Subsidiaries,
          would be classified as "Other Loans Specially Mentioned",
          "Special Mention", "Substandard", "Doubtful", "Loss",
          "Classified", "Criticized", "Credit Risk Assets",
          "Concerned Loans" or words of similar import.  The
          financial position of the Company and its Subsidiaries on
          a consolidated basis under or with respect to each such
          instrument has been reflected in the books and records of
          the Company and such Subsidiaries in accordance with GAAP
          consistently applied, and no open exposure of the Company
          or any of its Subsidiaries with respect to any such
          instrument (or with respect to multiple instruments with
          respect to any single counterparty) exceeds $500,000. 

                    3.24.  Opinion.  The Company has received a
          written opinion, dated the date hereof, from Keefe,
          Bruyette to the effect that, subject to the terms,
          conditions and qualifications set forth therein, as of
          the date thereof the consideration to be received by the
          stockholders of the Company pursuant to this Agreement is
          fair to such stockholders from a financial point of view. 
          Such opinion has not been amended or rescinded as of the
          date of this Agreement.

                    3.25.  Assistance Agreements.  Except as set
          forth in Section 3.25 of the Company Disclosure Schedule,
          neither the Company nor any of its Subsidiaries is a
          party to any agreement or arrangement entered into in
          connection with the consummation of a federally assisted
          acquisition of a depository institution pursuant to which
          the Company or any of its Subsidiaries is entitled to
          receive financial assistance or indemnification from any
          governmental agency.

                    3.26.  Approvals.  As of the date of this
          Agreement, the Company knows of no reason why all
          regulatory approvals required for the consummation of the
          transactions contemplated hereby (including, without
          limitation, the Merger and the Subsidiary Merger) should
          not be obtained without the imposition of a Burdensome
          Condition (as defined below).

                    3.27.  Loan Portfolio.  Except as set forth in
          Section 3.27 of the Company Disclosure Schedule, neither
          the Company nor any of its Subsidiaries is a party to any
          written or oral (i) loan agreement, note or borrowing
          arrangement (including, without limitation, leases,
          credit enhancements, commitments, guarantees and
          interest-bearing assets) (collectively, "Loans"), other
          than Loans the unpaid principal balance of which does not
          exceed $50,000, under the terms of which the obligor is,
          as of the date of this Agreement, over 90 days delinquent
          in payment of principal or interest or in default of any
          other provision, or (ii) Loan with any director,
          executive officer or ten percent stockholder of the
          Company or any of its Subsidiaries, or to the best
          knowledge of the Company, any person, corporation or
          enterprise controlling, controlled by or under common
          control with any of the foregoing.  Section 3.27 of the
          Company Disclosure Schedule sets forth (i) all of the
          Loans in original principal amount in excess of $50,000
          of the Company or any of its Subsidiaries that as of the
          date of this Agreement are classified by any bank
          examiner (whether regulatory or internal) as "Other Loans
          Specially Mentioned", "Special Mention", "Substandard",
          "Doubtful", "Loss", "Classified", "Criticized", "Credit
          Risk Assets", "Concerned Loans", "Watch List" or words of
          similar import, together with the principal amount of and
          accrued and unpaid interest on each such Loan and the
          identity of the borrower thereunder, and (ii) by category
          of Loan (i.e., commercial, consumer, etc.), all of the
          other Loans of the Company and its Subsidiaries that as
          of the date of this Agreement are classified as such,
          together with the aggregate principal amount of and
          accrued and unpaid interest on such Loans by category. 
          The Company shall promptly inform Buyer in writing of any
          Loan that becomes classified in the manner described in
          the previous sentence, or any Loan the classification of
          which is changed, at any time after the date of this
          Agreement.

                                  ARTICLE IV

                        REPRESENTATIONS AND WARRANTIES
                                   OF BUYER

                    Buyer hereby represents and warrants to the
          Company as follows:

                    4.1.  Corporate Organization.  (a)  Buyer is a
          corporation duly organized, validly existing and in good
          standing under the laws of the State of Delaware.  Buyer
          has the corporate power and authority to own or lease all
          of its properties and assets and to carry on its business
          as it is now being conducted, and is duly licensed or
          qualified to do business in each jurisdiction in which
          the nature of the business conducted by it or the
          character or location of the properties and assets owned
          or leased by it makes such licensing or qualification
          necessary, except where the failure to be so licensed or
          qualified would not have a Material Adverse Effect on
          Buyer.  Buyer is duly registered as a bank holding
          company under the BHC Act.  The Certificate of
          Incorporation and By-laws of Buyer, copies of which have
          previously been made available to the Company, are true,
          complete and correct copies of such documents as in
          effect as of the date of this Agreement.

                         (b)  New York Bank is a bank duly
          organized, validly existing and in good standing under
          the laws of the State of New York.  The deposit accounts
          of New York Bank are insured by the FDIC through the Bank
          Insurance Fund to the fullest extent permitted by law,
          and all premiums and assessments required in connection
          therewith have been paid by New York Bank.  Each of
          Buyer's other Subsidiaries is duly organized, validly
          existing and in good standing under the laws of the
          jurisdiction of its incorporation.  Each Subsidiary of
          Buyer has the corporate power and authority to own or
          lease all of its properties and assets and to carry on
          its business as it is now being conducted, and is duly
          licensed or qualified to do business in each jurisdiction
          in which the nature of the business conducted by it or
          the character or location of the properties and assets
          owned or leased by it makes such licensing or
          qualification necessary, except where the failure to be
          so licensed or qualified would not have a Material
          Adverse Effect on Buyer.  The articles of organization
          and by-laws of New York Bank, copies of which have
          previously been made available to the Company, are true,
          complete and correct copies of such documents as in
          effect as of the date of this Agreement.

                         (c)  The minute books of Buyer and each of
          its Subsidiaries contain true, complete and accurate
          records in all material respects of all meetings and
          other corporate actions held or taken since December 31,
          1991 of their respective stockholders and Boards of
          Directors (including committees of their respective
          Boards of Directors).

                    4.2.  Capitalization.  (a)  As of the date of
          this Agreement, the authorized capital stock of Buyer
          consists of 50,000,000 shares of Buyer Common Stock and
          10,000,000 shares of preferred stock, par value $1.00 per
          share ("Buyer Preferred Stock").  As of June 20, 1994,
          there were 14,248,799 shares of Buyer Common Stock and no
          shares of Buyer Preferred Stock issued and outstanding,
          and 487 shares of Buyer Common Stock held in Buyer's
          treasury.  As of the date of this Agreement, no shares of
          Buyer Common Stock or Buyer Preferred Stock were reserved
          for issuance, except that 657,820 shares of Buyer Common
          Stock were reserved for issuance pursuant to the Buyer's
          dividend reinvestment and stock purchase plans and
          described in Section 4.2(a) of the Disclosure Schedule
          which is being delivered by Buyer to the Company herewith
          (the "Buyer Disclosure Schedule"), 580,139 shares of
          Buyer Common Stock were reserved for issuance upon the
          exercise of stock options pursuant to the Buyer 1982
          Incentive Stock Option Plan, the Buyer 1985 Incentive
          Stock Option Plan and the Buyer 1987 Long Term Incentive
          Plan; the Buyer's 1989 Executive Stock Option Plan and
          the Buyer's 1994 Key Employee Stock Plan (collectively,
          the "Buyer Stock Plans"), 1,100,474 shares of Buyer
          Common Stock were reserved for issuance upon exercise of
          warrants under the warrant agreements listed on Section
          4.2(a) of the Buyer Disclosure Schedule, and 500,000
          shares of Buyer Series A Junior Participating Preferred
          Stock were reserved for issuance upon exercise of the
          rights (the "Buyer Rights") distributed to holders of
          Buyer Common Stock pursuant to the Shareholder Rights
          Agreement, dated as of February 28, 1989, between Buyer
          and The North Fork Bank, as Rights Agent (the "Buyer
          Shareholder Rights Agreement").  All of the issued and
          outstanding shares of Buyer Common Stock and Buyer
          Preferred Stock have been duly authorized and validly
          issued and are fully paid, nonassessable and free of
          preemptive rights, with no personal liability attaching
          to the ownership thereof.  As of the date of this
          Agreement, except as referred to above or reflected in
          Section 4.2(a) of the Buyer Disclosure Schedule and the
          Buyer Shareholder Rights Agreement, Buyer does not have
          and is not bound by any outstanding subscriptions,
          options, warrants, calls, commitments or agreements of
          any character calling for the purchase or issuance of any
          shares of Buyer Common Stock or Buyer Preferred Stock or
          any other equity securities of Buyer or any securities
          representing the right to purchase or otherwise receive
          any shares of Buyer Common Stock or Buyer Preferred
          Stock.  The shares of Buyer Common Stock to be issued
          pursuant to the Merger will be duly authorized and
          validly issued and, at the Effective Time, all such
          shares will be fully paid, nonassessable and free of
          preemptive rights, with no personal liability attaching
          to the ownership thereof.


                         (b)  Section 4.2(b) of the Buyer
          Disclosure Schedule sets forth a true and correct list of
          all of the Buyer Subsidiaries as of the date of this
          Agreement.  Except as set forth in Section 4.2(b) of the
          Buyer Disclosure Schedule, Buyer owns, directly or
          indirectly, all of the issued and outstanding shares of
          capital stock of each of the Subsidiaries of the Buyer,
          free and clear of all liens, charges, encumbrances and
          security interests whatsoever, and all of such shares are
          duly authorized and validly issued and are fully paid,
          nonassessable and free of preemptive rights, with no
          personal liability attaching to the ownership thereof. 
          As of the date of this Agreement, no Subsidiary of the
          Buyer has or is bound by any outstanding subscriptions,
          options, warrants, calls, commitments or agreements of
          any character with any party that is not a direct or
          indirect Subsidiary of Buyer calling for the purchase or
          issuance of any shares of capital stock or any other
          equity security of such Subsidiary or any securities
          representing the right to purchase or otherwise receive
          any shares of capital stock or any other equity security
          of such Subsidiary.

                    4.3.  Authority; No Violation.  (a)  Buyer has
          full corporate power and authority to execute and deliver
          this Agreement and to consummate the transactions
          contemplated hereby.  The execution and delivery of this
          Agreement and the consummation of the transactions
          contemplated hereby have been duly and validly approved
          by the Board of Directors of Buyer.  The Board of
          Directors of Buyer has directed that this Agreement and
          the transactions contemplated hereby be submitted to
          Buyer's stockholders for approval at a meeting of such
          stockholders and, except for the adoption of this
          Agreement by the requisite vote of Buyer's stockholders,
          no other corporate proceedings on the part of Buyer are
          necessary to consummate the transactions contemplated
          hereby.  This Agreement has been duly and validly
          executed and delivered by Buyer and (assuming due
          authorization, execution and delivery by the Company)
          constitutes a valid and binding obligation of Buyer,
          enforceable against Buyer in accordance with its terms,
          except as enforcement may be limited by general
          principles of equity whether applied in a court of law or
          a court of equity and by bankruptcy, insolvency and
          similar laws affecting creditors' rights and remedies
          generally.

                         (b)  New York Bank has full corporate
          power and authority to execute and deliver the Bank
          Merger Agreement and to consummate the transactions
          contemplated thereby.  The execution and delivery of the
          Bank Merger Agreement and the consummation of the
          transactions contemplated thereby will be duly and
          validly approved by the Board of Directors of New York
          Bank.  Upon the due and valid approval of the Bank Merger
          Agreement by Buyer as the sole stockholder of New York
          Bank, and by the Board of Directors of New York Bank, no
          other corporate proceedings on the part of New York Bank
          will be necessary to consummate the transactions
          contemplated thereby.  The Bank Merger Agreement, upon
          execution and delivery by New York Bank, will be duly and
          validly executed and delivered by New York Bank and will
          (assuming due authorization, execution and delivery by
          the Company Bank) constitute a valid and binding
          obligation of New York Bank, enforceable against New York
          Bank in accordance with its terms, except as enforcement
          may be limited by general principles of equity whether
          applied in a court of law or a court of equity and by
          bankruptcy, insolvency and similar laws affecting
          creditors' rights and remedies generally.

                         (c)  Except as set forth in Section 4.3(c)
          of the Buyer Disclosure Schedule, neither the execution
          and delivery of this Agreement by Buyer or the Bank
          Merger Agreement by New York Bank, nor the consummation
          by Buyer or New York Bank, as the case may be, of the
          transactions contemplated hereby or thereby, nor
          compliance by Buyer or New York Bank, as the case may be,
          with any of the terms or provisions hereof or thereof,
          will (i) violate any provision of the Certificate of
          Incorporation or By-Laws of Buyer, or the articles of
          incorporation or by-laws or similar governing documents
          of any of its Subsidiaries or (ii) assuming that the
          consents and approvals referred to in Section 4.4 are
          duly obtained, (x) violate any statute, code, ordinance,
          rule, regulation, judgment, order, writ, decree or
          injunction applicable to Buyer or any of its Subsidiaries
          or any of their respective properties or assets, or (y)
          violate, conflict with, result in a breach of any
          provision of or the loss of any benefit under, constitute
          a default (or an event which, with notice or lapse of
          time, or both, would constitute a default) under, result
          in the termination of or a right of termination or
          cancellation under, accelerate the performance required
          by, or result in the creation of any lien, pledge,
          security interest, charge or other encumbrance upon any
          of the respective properties or assets of Buyer or any of
          its Subsidiaries under, any of the terms, conditions or
          provisions of any note, bond, mortgage, indenture, deed
          of trust, license, lease, agreement or other instrument
          or obligation to which Buyer or any of its Subsidiaries
          is a party, or by which they or any of their respective
          properties or assets may be bound or affected, except (in
          the case of clause (y) above) for such violations,
          conflicts, breaches or defaults which either individually
          or in the aggregate will not have or be reasonably likely
          to have a Material Adverse Effect on Buyer.

                    4.4.  Consents and Approvals.  Except for (a)
          the filing of applications and notices, as applicable,
          with the Federal Reserve Board under the Oakar Amendment
          to the Federal Deposit Insurance Act and the BHC Act, and
          approval of such applications and notices, (b) the filing
          of applications with the FDIC under the Bank Merger Act
          and approval of such applications, (c) the filing of
          applications with the OTS and approval of such
          applications, (d) the State Banking Approvals, (e) the
          filing with the SEC of the Proxy Statement and the S-4,
          (f) the approval of this Agreement by the requisite vote
          of the stockholders of Buyer, (g) the filing of the
          Certificate of Merger with the Secretary, (h) such
          filings and approvals as are required to be made or
          obtained under the securities or "Blue Sky" laws of
          various states in connection with the issuance of the
          shares of Buyer Common Stock pursuant to this Agreement,
          (i) filings required by the Bank Merger Agreement, (j)
          the approval of the Bank Merger Agreement by the
          stockholder of New York Bank, and (k) such filings,
          authorizations or approvals as may be set forth in
          Section 4.4 of the Buyer Disclosure Schedule, no consents
          or approvals of or filings or registrations with any
          Governmental Entity or with any third party are necessary
          in connection with (1) the execution and delivery by
          Buyer of this Agreement, (2) the consummation by Buyer of
          the Merger and the other transactions contemplated
          hereby, (3) the execution and delivery by New York Bank
          of the Bank Merger Agreement, and (4) the consummation of
          New York Bank of the transactions contemplated by the
          Bank Merger Agreement.  

                    4.5.  Financial Statements.  Buyer has
          previously delivered to the Company copies of (a) the
          consolidated balance sheets of Buyer and its Subsidiaries
          as of December 31 for the fiscal years 1992 and 1993 and
          the related consolidated statements of income, changes in
          shareholders' equity and cash flows for the fiscal years
          1991 through 1993, inclusive, as reported in Buyer's
          Annual Report on Form 10-K for the fiscal year ended
          December 31, 1993 filed with the SEC under the Exchange
          Act, in each case accompanied by the audit report of KPMG
          Peat Marwick, independent public accountants with respect
          to Buyer, and (b) the unaudited consolidated balance
          sheet of Buyer and its Subsidiaries as of March 31, 1994
          and March 31, 1993 and the related unaudited consolidated
          statements of income, changes in shareholders' equity and
          cash flows for the three-month periods then ended as
          reported in Buyer's Quarterly Report on Form 10-Q for the
          period ended March 31, 1994 filed with the SEC under the
          Exchange Act.  The December 31, 1993 consolidated balance
          sheet of Buyer (including the related notes, where
          applicable) fairly presents the consolidated financial
          position of Buyer and its Subsidiaries as of the date
          thereof, and the other financial statements referred to
          in this Section 4.5 (including the related notes, where
          applicable) fairly present and the financial statements
          referred to in Section 6.9 hereof will fairly present
          (subject, in the case of the unaudited statements, to
          recurring audit adjustments normal in nature and amount),
          the results of the consolidated operations and changes in
          shareholders' equity and consolidated financial position
          of Buyer and its Subsidiaries for the respective fiscal
          periods or as of the respective dates therein set forth;
          each of such statements (including the related notes,
          where applicable) comply, and the financial statements
          referred to in Section 6.9 hereof will comply, in all
          material respects with applicable accounting requirements
          and with the published rules and regulations of the SEC
          with respect thereto; and each of such statements
          (including the related notes, where applicable) has been,
          and the financial statements referred to in Section 6.9
          hereof will be, prepared in accordance with GAAP
          consistently applied during the periods involved, except
          as indicated in the notes thereto or, in the case of
          unaudited statements, as permitted by Form 10-Q.  The
          books and records of Buyer and its Subsidiaries have
          been, and are being, maintained in all material respects
          in accordance with GAAP and any other applicable legal
          and accounting requirements and reflect only actual
          transactions.

                    4.6.  Broker's Fees.  Neither Buyer nor any
          Subsidiary of Buyer, nor any of their respective officers
          or directors, has employed any broker or finder or
          incurred any liability for any broker's fees, commissions
          or finder's fees in connection with any of the
          transactions contemplated by this Agreement, the Bank
          Merger Agreement or the Option Agreement, except that
          Buyer has engaged, and will pay a fee or commission to
          M.A. Schapiro & Co.

                    4.7.  Absence of Certain Changes or Events. 
          Except as may be set forth in Section 4.7 of the Buyer
          Disclosure Schedule, or as disclosed in Buyer's Quarterly
          Report on Form 10-Q for the quarter ended March 31, 1994
          (a true, complete and correct copy of which has
          previously been delivered to the Company), since December
          31, 1993, (i) neither Buyer nor any of its Subsidiaries
          has incurred any material liability, except in the
          ordinary course of their business consistent with their
          past practices, and (ii) no event has occurred which has
          caused, or is reasonably likely to cause, individually or
          in the aggregate, a Material Adverse Effect on Buyer.

                    4.8.  Legal Proceedings.  (a)  Except as set
          forth in Section 4.8 of the Buyer Disclosure Schedule or
          in Buyer's Quarterly Report on Form 10-Q for the quarter
          ended March 31, 1994, neither Buyer nor any of its
          Subsidiaries is a party to any and there are no pending
          or, to the best of Buyer's knowledge, threatened,
          material legal, administrative, arbitral or other
          proceedings, claims, actions or governmental or
          regulatory investigations of any nature against Buyer or
          any of its Subsidiaries or challenging the validity or
          propriety of the transactions contemplated by this
          Agreement, the Bank Merger Agreement or the Option
          Agreement as to which there is a reasonable probability
          of an adverse determination and which, if adversely
          determined, would have or be reasonably likely to have a
          Material Adverse Effect on Buyer.  

                         (b)  There is no injunction, order,
          judgment, decree, or regulatory restriction imposed upon
          Buyer, any of its Subsidiaries or the assets of Buyer or
          any of its Subsidiaries which has had, or could
          reasonably be expected to have, a Material Adverse Effect
          on Buyer.

                    4.9.  Compliance with Applicable Law.  Buyer
          and each of its Subsidiaries holds, and has at all times
          held, all material licenses, franchises, permits and
          authorizations necessary for the lawful conduct of their
          respective businesses under and pursuant to all, and have
          complied with and are not in default in any respect under
          any, applicable law, statute, order, rule, regulation,
          policy and/or guideline of any Governmental Entity
          relating to Buyer or any of its Subsidiaries, except
          where the failure to hold such license, franchise, permit
          or authorization or such non-compliance or default would
          not, individually or in the aggregate, have, or be
          reasonably likely to have, a Material Adverse Effect on
          Buyer, and neither Buyer nor any of its Subsidiaries
          knows of, or has received notice of violation of, any
          material violations of any of the above.

                    4.10.  SEC Reports.  Buyer has previously made
          available to the Company an accurate and complete copy of
          each (a) final registration statement, prospectus,
          report, schedule and definitive proxy statement filed
          since January 1, 1990 by Buyer with the SEC pursuant to
          the Securities Act or the Exchange Act (the "Buyer
          Reports") and (b) communication mailed by Buyer to its
          shareholders since January 1, 1990, and no such
          registration statement, prospectus, report, schedule,
          proxy statement or communication contained any untrue
          statement of a material fact or omitted to state any
          material fact required to be stated therein or necessary
          in order to make the statements therein, in light of the
          circumstances in which they were made, not misleading,
          except that information as of a later date shall be
          deemed to modify information as of an earlier date. 
          Buyer has timely filed all Buyer Reports and other
          documents required to be filed by it under the Securities
          Act and the Exchange Act, and, as of their respective
          dates, all Buyer Reports complied in all material
          respects with the published rules and regulations of the
          SEC with respect thereto.

                    4.11.  Buyer Information.  The information
          relating to Buyer and its Subsidiaries to be contained in
          the Proxy Statement and the S-4, or in any other document
          filed with any other regulatory agency in connection
          herewith, will not contain any untrue statement of a
          material fact or omit to state a material fact necessary
          to make the statements therein, in light of the
          circumstances in which they are made, not misleading. 
          The S-4 (except for such portions thereof that relate
          only to the Company or any of its Subsidiaries) will
          comply in all material respects with the provisions of
          the Exchange Act and the rules and regulations
          thereunder.

                    4.12.  Ownership of Company Common Stock;
          Affiliates and Associates.  (a)  Except for the Stock
          Option Agreement, neither Buyer nor any of its affiliates
          or associates (as such terms are defined under the
          Exchange Act), (i) beneficially own, directly or
          indirectly, or (ii) is a party to any agreement,
          arrangement or understanding for the purpose of
          acquiring, holding, voting or disposing of, in each case,
          any shares of capital stock of the Company (other than
          Trust Account Shares and DPC Shares); and

                         (b)  Neither Buyer nor any of its
          Subsidiaries is an "affiliate" (as such term is defined
          in DGCL SECTION 203(c)(1)), an "associate" (as such term is
          defined in DGCL SECTION 203(c)(2)) of the Company or an
          "Interested Stockholder" (as such term is defined in
          Section 8 of the Company's Certificate of Incorporation).

                    4.13.  Taxes.  Except as set forth in Section
          4.13 of the Buyer Disclosure Schedule, each of Buyer and
          its Subsidiaries has (i) duly and timely filed or will
          duly and timely file (including applicable extensions
          granted without penalty) all Tax Returns required to be
          filed at or prior to the Effective Time, and such Tax
          Returns which have heretofore been filed are, and those
          to be hereinafter filed will be, true, correct and
          complete, and (ii) paid in full or have made adequate
          provision for on the financial statements of Buyer (in
          accordance with GAAP) all Taxes and will pay in full or
          make adequate provision for all Taxes.  There are no
          material liens for Taxes upon the assets of either Buyer
          or its Subsidiaries except for statutory liens for
          current Taxes not yet due.  Except as set forth in
          Section 4.13 of the Buyer Disclosure Schedule, neither
          Buyer nor any of its Subsidiaries has requested any
          extension of time within which to file any Tax Returns in
          respect of any fiscal year which have not since been
          filed and no request for waivers of the time to assess
          any Taxes are pending or outstanding.  The federal and
          state income Tax Returns of Buyer and its Subsidiaries
          have been audited by the Internal Revenue Service or
          appropriate state tax authorities with respect to those
          periods and jurisdictions set forth on Section 4.13 of
          the Buyer Disclosure Schedule.  Except as set forth in
          Section 4.13 of the Buyer Disclosure Schedule, neither
          Buyer nor any of its Subsidiaries (i) is a party to any
          agreement providing for the allocation or sharing of
          Taxes (other than the allocation of federal income taxes
          as provided by Regulation 1.1552-1(a)(1) under the Code);
          (ii) is required to include in income any adjustment
          pursuant to Section 481(a) of the Code, by reason of the
          voluntary change in accounting method (nor has any taxing
          authority proposed in writing any such adjustment or
          change of accounting method); or (iii) has filed a
          consent pursuant to Section 341(f) of the Code.

                    4.14.  Employees.  (a)  Section 4.14(a) of the
          Buyer Disclosure Schedule sets forth a true and complete
          list of each employee benefit plan, arrangement or
          agreement that is maintained or contributed to or
          required to be contributed to as of the date of this
          Agreement (the "Buyer Plans") by Buyer, any of its
          Subsidiaries or by any trade or business, whether or not
          incorporated (a "Buyer ERISA Affiliate"), all of which
          together with Buyer would be deemed a "single employer"
          within the meaning of Section 4001 of ERISA, for the
          benefit of any employee or former employee of Buyer, any
          Subsidiary or any ERISA Affiliate.

                    (b)  Except as set forth in Section 4.14(b) of
          the Buyer Disclosure Schedule, (i) each of the Buyer
          Plans has been operated and administered in all material
          respects in accordance with its terms and applicable law,
          including but not limited to ERISA and the Code, (ii)
          each of the Buyer Plans intended to be "qualified" within
          the meaning of Section 401(a) of the Code has either (1)
          received a favorable determination letter from the IRS,
          or (2) is or will be the subject of an application for a
          favorable determination letter, and Buyer is not aware of
          any circumstances likely to result in the revocation or
          denial of any such favorable determination letter, (iii)
          with respect to each Buyer Plan which is subject to Title
          IV of ERISA, the present value of accrued benefits under
          such Buyer Plan, based upon the actuarial assumptions
          used for funding purposes in the most recent actuarial
          report prepared by such Buyer Plan's actuary with respect
          to such Buyer Plan, did not, as of its latest valuation
          date, exceed the then current value of the assets of such
          Buyer Plan allocable to such accrued benefits, (iv) no
          Plan provides benefits, including without limitation
          death or medical benefits (whether or not insured), with
          respect to current or former employees of Buyer, its
          Subsidiaries or any ERISA Affiliate beyond their
          retirement or other termination of service, other than
          (w) coverage mandated by applicable law, (x) death
          benefits or retirement benefits under any "employee
          pension plan," as that term is defined in Section 3(2) of
          ERISA, (y) deferred compensation benefits accrued as
          liabilities on the books of Buyer, its Subsidiaries or
          the ERISA Affiliates or (z) benefits the full cost of
          which is borne by the current or former employee (or his
          beneficiary), (v) no liability under Title IV of ERISA
          has been incurred by Buyer, its Subsidiaries or any Buyer
          ERISA Affiliate that has not been satisfied in full, (vi)
          no Buyer Plan is a "multiemployer pension plan," as such
          term is defined in Section 3(37) of ERISA, (vii) all
          contributions or other amounts payable by Buyer, its
          Subsidiaries or any ERISA Affiliate as of the Effective
          Time with respect to each Plan in respect of current or
          prior plan years have been paid or accrued in accordance
          with generally accepted accounting practices and Section
          412 of the Code, (viii) neither Buyer, its Subsidiaries
          nor any ERISA Affiliate has engaged in a transaction in
          connection with which Buyer, its Subsidiaries or any
          ERISA Affiliate could be subject to either a civil
          penalty assessed pursuant to Section 409 or 502(i) of
          ERISA or a tax imposed pursuant to Section 4975 or 4976
          of the Code, (ix) there are no pending, or, to the best
          knowledge of Buyer, threatened or anticipated claims
          (other than routine claims for benefits) by, on behalf of
          or against any of the Buyer Plans or any trusts related
          thereto and (x) the consummation of the transactions
          contemplated by this Agreement will not (y) entitle any
          current or former employee or officer of Buyer or any
          ERISA Affiliate to severance pay, termination pay or any
          other payment, except as expressly provided in this
          Agreement or (z) accelerate the time of payment or
          vesting or increase in the amount of compensation due any
          such employee or officer.

                    4.15.  Agreements with Regulatory Agencies. 
          Except as set forth in Section 4.15 of the Buyer
          Disclosure Schedule or as disclosed in Buyer's Annual
          Report on Form 10-K for the year ended December 31, 1993,
          neither Buyer nor any of its Subsidiaries is subject to
          any cease-and-desist or other order issued by, or is a
          party to any written agreement, consent agreement or
          memorandum of understanding with, or is a party to any
          commitment letter or similar undertaking to, or is
          subject to any order or directive by, or is a recipient
          of any extraordinary supervisory letter from, or has
          adopted any board resolutions at the request of (each,
          whether or not set forth in Section 4.15 of the Buyer
          Disclosure Schedule, a "Buyer Regulatory Agreement"), any
          Regulatory Agency or other Governmental Entity that
          restricts the conduct of its business or that in any
          manner relates to its capital adequacy, its credit
          policies, its management or its business, nor has Buyer
          or any of its Subsidiaries been advised by any Regulatory
          Agency or other Governmental Entity that it is
          considering issuing or requesting any Regulatory
          Agreement.

                    4.16.  Undisclosed Liabilities.  Except (a) as
          set forth in Section 4.16 of the Buyer Disclosure
          Schedule, (b) for those liabilities that are fully
          reflected or reserved against on the consolidated balance
          sheet of Buyer included in its Form 10-Q for the period
          ended March 31, 1994 and (c) for liabilities incurred in
          the ordinary course of business consistent with past
          practice since March 31, 1994 that, either alone or when
          combined with all similar liabilities, have not had, and
          could not reasonably be expected to have, a Material
          Adverse Effect on Buyer, neither Buyer nor any of its
          Subsidiaries has incurred any liability of any nature
          whatsoever (whether absolute, accrued, contingent or
          otherwise and whether due or to become due).

                    4.17.  Administration of Fiduciary Accounts. 
          Buyer and each of its Subsidiaries has properly
          administered in all material respects all accounts for
          which it acts as a fiduciary, including but not limited
          to accounts for which it serves as a trustee, agent,
          custodian, personal representative, guardian, conservator
          or investment advisor, in accordance with the terms of
          the governing documents and applicable state and federal
          law and regulation and common law.  Neither Buyer nor any
          of its Subsidiaries nor any of their respective
          directors, officers or employees has committed any breach
          of trust with respect to any such fiduciary account which
          has had or could reasonably be expected to have a
          Material Adverse Effect on Buyer, and the accountings for
          each such fiduciary account are true and correct in all
          material respects and accurately reflect the assets of
          such fiduciary account.

                    4.18.  Approvals.  As of the date of this
          Agreement, Buyer knows of no reason why all regulatory
          approvals required for the consummation of the
          transactions contemplated hereby (including, without
          limitation, the Merger and the Subsidiary Merger) should
          not be obtained without the imposition of a Burdensome
          Condition.

                    4.19.  Reports.  Buyer and each of its
          Subsidiaries have timely filed all material reports,
          registrations and statements, together with any
          amendments required to be made with respect thereto, that
          they were required to file since December 31, 1991 with
          any Regulatory Agency, and all other material reports and
          statements required to be filed by them since December
          31, 1991, including, without limitation, any report or
          statement required to be filed pursuant to the laws,
          rules or regulations of the United States, the Federal
          Reserve Board, the FDIC, any State Regulator or any SRO,
          and have paid all fees and assessments due and payable in
          connection therewith.  Except for normal examinations
          conducted by a Regulatory Agency in the regular course of
          the business of Buyer and its Subsidiaries, except as set
          forth in Section 4.19 of Buyer Disclosure Schedule, no
          Regulatory Agency has initiated any proceeding or, to the
          best knowledge of Buyer, investigation into the business
          or operations of Buyer or any of its Subsidiaries since
          December 31, 1991.  There is no unresolved material
          violation, criticism, or exception by any Regulatory
          Agency with respect to any report or statement relating
          to any examinations of Buyer or any of its Subsidiaries.

                    4.20.  Environmental Matters.  Except as set
          forth in Section 4.20 of the Buyer Disclosure Schedule:

                         (a)  Each of Buyer, its Subsidiaries, the
          Participation Facilities and the Loan Properties (each as
          hereinafter defined) are, and have been, in compliance
          with Environmental Laws, except for violations which,
          either individually or in the aggregate, have not had and
          cannot reasonably be expected to have a Material Adverse
          Effect on Buyer;

                         (b)  There is no suit, claim, action or
          proceeding, pending or threatened, before any
          Governmental Entity or other forum in which Buyer, any of
          its Subsidiaries, any Participation Facility or any Loan
          Property, has been or, with respect to threatened
          proceedings, may be, named as a defendant (x) for alleged
          noncompliance (including by any predecessor), with any
          Environmental Laws, or (y) relating to the release,
          threatened release or exposure to any material whether or
          not occurring at or on a site owned, leased or operated
          by Buyer or any of its Subsidiaries, any Participation
          Facility or any Loan Property, except where such
          noncompliance or release has not resulted, and cannot be
          reasonably expected to result, either individually or in
          the aggregate, a Material Adverse Effect on Buyer;

                         (c)  During the period of (x) Buyer's or
          any of its Subsidiaries' ownership or operation of any of
          their respective current properties, (y) Buyer's or any
          of its Subsidiaries' participation in the management of
          any Participation Facility, or (z) Buyer's or any of its
          Subsidiaries' holding of a security interest in a Loan
          Property, there has been no release of materials in, on,
          under or affecting any such property, except where such
          release has not had and cannot reasonably be expected to
          result in, either individually or in the aggregate, a
          Material Adverse Effect on Buyer.  Prior to the period of
          (x) Buyer's or any of its Subsidiaries' ownership or
          operation of any of their respective current properties,
          (y) Buyer's or any of its Subsidiaries' participation in
          the management of any Participation Facility, or (z)
          Buyer's or any of its Subsidiaries' holding of a security
          interest in a Loan Property, there was no release or
          threatened release of materials in, on, under or
          affecting any such property, Participation Facility or
          Loan Property, except where such release has not had and
          cannot be reasonably expected to have, either
          individually or in the aggregate, a Material Adverse
          Effect on Buyer; and

                         (d)  The following definitions apply for
          purposes of this Section 4.20: (x) "Loan Property" means
          any property in which Buyer or any of its Subsidiaries
          holds a security interest, and, where required by the
          context, said term means the owner or operator of such
          property; and (y) "Participation Facility" means any
          facility in which Buyer or any of its Subsidiaries
          participates in the management and, where required by the
          context, said term means the owner or operator of such
          property.

                    4.21.  Derivative Transactions.  Except as set
          forth in Section 4.21 of the Buyer Disclosure Schedule,
          since December 31, 1993, neither Buyer nor any of its
          Subsidiaries has engaged in transactions in or involving
          forwards, futures, options on futures, swaps or other
          derivative instruments except (i) as agent on the order
          and for the account of others, or (ii) as principal for
          purposes of hedging interest rate risk on U.S. dollar-
          denominated securities and other financial instruments. 
          None of the counterparties to any contract or agreement
          with respect to any such instrument is in default with
          respect to such contract or agreement and no such
          contract or agreement, were it to be a Loan held by Buyer
          or any of its Subsidiaries, would be classified as "Other
          Loans Specially Mentioned", "Special Mention",
          "Substandard", "Doubtful", "Loss", "Classified",
          "Criticized", "Credit Risk Assets", "Concerned Loans" or
          words of similar import.  The financial position of Buyer
          and its Subsidiaries on a consolidated basis under or
          with respect to each such instrument has been reflected
          in the books and records of Buyer and such Subsidiaries
          in accordance with GAAP consistently applied, and no open
          exposure of Buyer or any of its Subsidiaries with respect
          to any such instrument (or with respect to multiple
          instruments with respect to any single counterparty)
          exceeds $500,000.

                    4.22.  Loan Portfolio.  Except as set forth in
          Section 4.22 of the Buyer Disclosure Schedule, neither
          Buyer nor any of its Subsidiaries is a party to any
          written or oral (i) Loan, other than Loans the unpaid
          principal balance of which does not exceed $50,000, under
          the terms of which the obligor is, as of the date of this
          Agreement, over 90 days delinquent in payment of
          principal or interest or in default of any other
          provision, or (ii) Loan as of the date of this Agreement
          with any director, executive officer or ten percent
          stockholder of Buyer or any of its Subsidiaries, or to
          the best knowledge of Buyer, any person, corporation or
          enterprise controlling, controlled by or under common
          control with any of the foregoing.  Section 4.22 of the
          Buyer Disclosure Schedule sets forth (i) all of the Loans
          in original principal amount in excess of $50,000 of
          Buyer or any of its Subsidiaries that as of the date of
          this Agreement are classified by any bank examiner
          (whether regulatory or internal) as "Other Loans
          Specially Mentioned", "Special Mention", "Substandard",
          "Doubtful", "Loss", "Classified", "Criticized", "Credit
          Risk Assets", "Concerned Loans", "Watch List" or words of
          similar import, together with the principal amount of and
          accrued and unpaid interest on each such Loan and the
          identity of the borrower thereunder, and (ii) by category
          of Loan (i.e., commercial, consumer, etc.), all of the
          other Loans of Buyer and its Subsidiaries that as of the
          date of this Agreement are classified as such, together
          with the aggregate principal amount of and accrued and
          unpaid interest on such Loans by category.  Buyer shall
          promptly inform the Company in writing of any Loan that
          becomes classified in the manner described in the
          previous sentence, or any Loan the classification of
          which is changed, at any time after the date of this
          Agreement.


                                  ARTICLE V

                  COVENANTS RELATING TO CONDUCT OF BUSINESS

                    5.1.  Covenants of the Company.  During the
          period from the date of this Agreement and continuing
          until the Effective Time, except as expressly
          contemplated or permitted by this Agreement, the Bank
          Merger Agreement or the Option Agreement or with the
          prior written consent of Buyer, the Company and its
          Subsidiaries shall carry on their respective businesses
          in the ordinary course consistent with past practice and
          consistent with prudent banking practice.  The Company
          will use its best efforts to (x) preserve its business
          organization and that of its Subsidiaries intact, (y)
          keep available to itself and Buyer the present services
          of the employees of the Company and its Subsidiaries and
          (z) preserve for itself and Buyer the goodwill of the
          customers of the Company and its Subsidiaries and others
          with whom business relationships exist.  Without limiting
          the generality of the foregoing, and except as set forth
          on Section 5.1 of the Company Disclosure Schedule or as
          otherwise contemplated by this Agreement or consented to
          in writing by Buyer, the Company shall not, and shall not
          permit any of its Subsidiaries to:

                         (a)  solely in the case of the Company,
          declare or pay any dividends on, or make other
          distributions in respect of, any of its capital stock,
          other than normal quarterly dividends in an amount of no
          more than $0.18 per share of Company Common Stock;

                         (b)  (i) split, combine or reclassify any
          shares of its capital stock or issue or authorize or
          propose the issuance of any other securities in respect
          of, in lieu of or in substitution for shares of its
          capital stock except upon the exercise or fulfillment of
          rights or options issued or existing pursuant to employee
          benefit plans, programs or arrangements, all to the
          extent outstanding and in existence on the date of this
          Agreement and in accordance with their present terms, and
          except pursuant to the Option Agreement, or (ii)
          repurchase, redeem or otherwise acquire (except for the
          acquisition of Trust Account Shares and DPC Shares, as
          such terms are defined in Section 1.4(b) hereof) any
          shares of the capital stock of the Company or any
          Subsidiary of the Company, or any securities convertible
          into or exercisable for any shares of the capital stock
          of the Company or any Subsidiary of the Company;

                         (c)  issue, deliver or sell, or authorize
          or propose the issuance, delivery or sale of, any shares
          of its capital stock or any securities convertible into
          or exercisable for, or any rights, warrants or options to
          acquire, any such shares, or enter into any agreement
          with respect to any of the foregoing, other than (i) the
          issuance of Company Common Stock pursuant to stock
          options or similar rights to acquire Company Common Stock
          granted pursuant to the Company Stock Plans and
          outstanding prior to the date of this Agreement, in each
          case in accordance with their present terms and (ii)
          pursuant to the Option Agreement;

                         (d)  amend its Certificate of
          Incorporation, By-laws or other similar governing
          documents;

                         (e)  authorize or permit any of its
          officers, directors, employees or agents to directly or
          indirectly solicit, initiate or encourage any inquiries
          relating to, or the making of any proposal which
          constitutes, a "takeover proposal" (as defined below),
          or, except to the extent legally required for the
          discharge of the fiduciary duties of the Board of
          Directors of the Company, recommend or endorse any
          takeover proposal, or participate in any discussions or
          negotiations, or provide third parties with any nonpublic
          information, relating to any such inquiry or proposal or
          otherwise facilitate any effort or attempt to make or
          implement a takeover proposal; provided, however, that
          the Company may communicate information about any such
          takeover proposal to its stockholders if, in the judgment
          of the Company's Board of Directors, based upon the
          advice of outside counsel, such communication is required
          under applicable law.  The Company will immediately cease
          and cause to be terminated any existing activities,
          discussions or negotiations previously conducted with any
          parties other than Buyer with respect to any of the
          foregoing.  The Company will take all actions necessary
          or advisable to inform the appropriate individuals or
          entities referred to in the first sentence hereof of the
          obligations undertaken in this Section 5.1(e).  The
          Company will notify Buyer immediately if any such
          inquiries or takeover proposals are received by, any such
          information is requested from, or any such negotiations
          or discussions are sought to be initiated or continued
          with, the Company, and the Company will promptly inform
          Buyer in writing of all of the relevant details with
          respect to the foregoing.  As used in this Agreement,
          "takeover proposal" shall mean any tender or exchange
          offer, proposal for a merger, consolidation or other
          business combination involving the Company or any
          Subsidiary of the Company or any proposal or offer to
          acquire in any manner a substantial equity interest in,
          or a substantial portion of the assets of, the Company or
          any Subsidiary of the Company other than the transactions
          contemplated or permitted by this Agreement, the Bank
          Merger Agreement and the Option Agreement;

                         (f)  make any capital expenditures other
          than the expenses which are set forth in Section 5.1(f)
          of the Company Disclosure Schedule and expenses which (i)
          are made in the ordinary course of business or are
          necessary to maintain existing assets in good repair and
          (ii) in any event are in an amount of no more than
          $50,000 individually and $50,000 in the aggregate;

                         (g)  enter into any new line of business;

                         (h)  acquire or agree to acquire, by
          merging or consolidating with, or by purchasing a
          substantial equity interest in or a substantial portion
          of the assets of, or by any other manner, any business or
          any corporation, partnership, association or other
          business organization or division thereof or otherwise
          acquire any assets, which would be material, individually
          or in the aggregate, to the Company, other than in
          connection with foreclosures, settlements in lieu of
          foreclosure or troubled loan or debt restructurings in
          the ordinary course of business consistent with prudent
          banking practices;

                         (i)  take any action that is intended or
          may reasonably be expected to result in any of its
          representations and warranties set forth in this
          Agreement being or becoming untrue in any material
          respect, or in any of the conditions to the Merger set
          forth in Article VII not being satisfied, or in a
          violation of any provision of this Agreement or the Bank
          Merger Agreement, except, in every case, as may be
          required by applicable law;

                         (j)  change its methods of accounting in
          effect at March 31, 1994, except as required by changes
          in GAAP or regulatory accounting principles as concurred
          to by the Company's independent auditors;

                         (k)  (i) except as required by applicable
          law or to maintain qualification pursuant to the Code,
          adopt, amend, renew or terminate any Plan or any
          agreement, arrangement, plan or policy between the
          Company or any Subsidiary of the Company and one or more
          of its current or former directors, officers or employees
          or (ii) except for normal increases in the ordinary
          course of business consistent with past practice or
          except as required by applicable law, increase in any
          manner the compensation or fringe benefits of any
          director, officer or employee or pay any benefit not
          required by any plan or agreement as in effect as of the
          date hereof (including, without limitation, the granting
          of stock options, stock appreciation rights, restricted
          stock, restricted stock units or performance units or
          shares);

                         (l)  take or cause to be taken any action
          which would disqualify the Merger as a "pooling of
          interests" for accounting purposes or a tax free
          reorganization under Section 368 of the Code, provided,
          however, that nothing contained herein shall limit the
          ability of Buyer to exercise its rights under the Option
          Agreement;

                         (m)  except as set forth in Section 5.1(m)
          of the Company Disclosure Schedule, other than activities
          in the ordinary course of business consistent with prior
          practice, sell, lease, encumber, assign or otherwise
          dispose of, or agree to sell, lease, encumber, assign or
          otherwise dispose of, any of its material assets,
          properties or other rights or agreements;

                         (n)  other than in the ordinary course of
          business consistent with past practice, incur any
          indebtedness for borrowed money, assume, guarantee,
          endorse or otherwise as an accommodation become
          responsible for the obligations of any other individual,
          corporation or other entity;

                         (o)  file any application to relocate or
          terminate the operations of any banking office of it or
          any of its Subsidiaries;

                         (p)  commit any act or omission which
          constitutes a material breach or default by the Company
          or any of its Subsidiaries under any Regulatory Agreement
          or under any material contract or material license to
          which the Company or any of its Subsidiaries is a party
          or by which any of them or their respective properties is
          bound;

                         (q)  make any equity investment or
          commitment to make such an investment in real estate or
          in any real estate development project, other than in
          connection with foreclosures, settlements in lieu of
          foreclosure or troubled loan or debt restructurings in
          the ordinary course of business consistent with prudent
          banking practices;

                         (r)  create, renew, amend or terminate or
          give notice of a proposed renewal, amendment or
          termination of, any material contract, agreement or lease
          for goods, services or office space to which the Company
          or any of its Subsidiaries is a party or by which the
          Company or any of its Subsidiaries or their respective
          properties is bound;

                         (s)  take any action which would cause the
          termination or cancellation by the FDIC of insurance in
          respect of the Company's deposits; or

                         (t)  agree to do any of the foregoing.

                    5.2.  Covenants of Buyer.  During the period
          from the date of this Agreement and continuing until the
          Effective Time, except as expressly contemplated or
          permitted by this Agreement, the Bank Merger Agreement or
          the Option Agreement or with the prior written consent of
          the Company, Buyer and its Subsidiaries shall carry on
          their respective businesses in the ordinary course
          consistent with past practice and consistent with prudent
          banking practice.  Buyer will use its best efforts to (x)
          preserve its business organization and that of its
          Subsidiaries intact and (y) preserve for itself and the
          Company the goodwill of the customers of Buyer and its
          Subsidiaries and others with whom business relationships
          exist.  Without limiting the generality of the foregoing
          and except as set forth on Section 5.2 of the Buyer
          Disclosure Schedule or as otherwise contemplated by this
          Agreement or consented to in writing by the Company,
          Buyer shall not, and shall not permit any of its
          Subsidiaries to:

                         (a)  solely in the case of Buyer, declare
          or pay any extraordinary or special dividends on or make
          any other extraordinary or special distributions in
          respect of any of its capital stock; provided, however,
          that nothing contained herein shall prohibit Buyer from
          increasing the quarterly cash dividend on the Buyer
          Common Stock;

                         (b)  take any action that is intended or
          may reasonably be expected to result in any of its
          representations and warranties set forth in this
          Agreement being or becoming untrue in any material
          respect, or in any of the conditions to the Merger set
          forth in Article VII not being satisfied or in a
          violation of any provision of this Agreement or the Bank
          Merger Agreement, except, in every case, as may be
          required by applicable law;

                         (c)  change its methods of accounting in
          effect at March 31, 1994, except in accordance with
          changes in GAAP or regulatory accounting principles as
          concurred to by Buyer's independent auditors;

                         (d)  take or cause to be taken any action
          which would disqualify the Merger as a "pooling of
          interests" for accounting purposes or a tax free
          reorganization under Section 368 of the Code, provided,
          however, that nothing contained herein shall limit the
          ability of Buyer to exercise its rights under the Option
          Agreement; or

                         (e)  agree to do any of the foregoing.

                                  ARTICLE VI

                            ADDITIONAL AGREEMENTS

                    6.1.  Regulatory Matters.  (a)  The Company
          shall promptly prepare and file with the SEC the Proxy
          Statement and Buyer shall promptly prepare and file with
          the SEC the S-4, in which the Proxy Statement will be
          included as a prospectus.  Each of the Company and Buyer
          shall use all reasonable efforts to have the S-4 declared
          effective under the Securities Act as promptly as
          practicable after such filing, and each of the Company
          and Buyer shall thereafter mail the Proxy Statement to
          each of its respective stockholders.  Buyer shall also
          use all reasonable efforts to obtain all necessary state
          securities law or "Blue Sky" permits and approvals
          required to carry out the transactions contemplated by
          this Agreement and the Bank Merger Agreement, and the
          Company shall furnish all information concerning the
          Company and the holders of Company Common Stock as may be
          reasonably requested in connection with any such action.

                         (b)  The parties hereto shall cooperate
          with each other and use their best efforts to promptly
          prepare and file all necessary documentation, to effect
          all applications, notices, petitions and filings, and to
          obtain as promptly as practicable all permits, consents,
          approvals and authorizations of all third parties and
          Governmental Entities which are necessary or advisable to
          consummate the transactions contemplated by this
          Agreement (including without limitation the Merger and
          the Subsidiary Merger) (it being understood that any
          amendments to the S-4 or a resolicitation of proxies as
          consequence of a subsequent proposed merger, stock
          purchase or similar acquisition by Buyer or any of its
          Subsidiaries shall not violate this covenant).  The
          Company and Buyer shall have the right to review in
          advance, and to the extent practicable each will consult
          the other on, in each case subject to applicable laws
          relating to the exchange of information, all the
          information relating to the Company or Buyer, as the case
          may be, and any of their respective Subsidiaries, which
          appear in any filing made with, or written materials
          submitted to, any third party or any Governmental Entity
          in connection with the transactions contemplated by this
          Agreement.  In exercising the foregoing right, each of
          the parties hereto shall act reasonably and as promptly
          as practicable.  The parties hereto agree that they will
          consult with each other with respect to the obtaining of
          all permits, consents, approvals and authorizations of
          all third parties and Governmental Entities necessary or
          advisable to consummate the transactions contemplated by
          this Agreement and each party will keep the other
          apprised of the status of matters relating to completion
          of the transactions contemplated herein.

                         (c)  Buyer and the Company shall, upon
          request, furnish each other with all information
          concerning themselves, their Subsidiaries, directors,
          officers and stockholders and such other matters as may
          be reasonably necessary or advisable in connection with
          the Proxy Statement, the S-4 or any other statement,
          filing, notice or application made by or on behalf of
          Buyer, the Company or any of their respective
          Subsidiaries to any Governmental Entity in connection
          with the Merger and the other transactions contemplated
          by this Agreement.

                              (d)  Buyer and the Company shall promptly
               furnish each other with copies of written communications
               received by Buyer or the Company, as the case may be, or
               any of their respective Subsidiaries, Affiliates or
               Associates (as such terms are defined in Rule 12b-2 under
               the Exchange Act as in effect on the date of this
               Agreement) from, or delivered by any of the foregoing to,
               any Governmental Entity in respect of the transactions
               contemplated hereby.

                         6.2.  Access to Information.  (a)  Upon
               reasonable notice and subject to applicable laws relating
               to the exchange of information, the Company shall, and
               shall cause each of its Subsidiaries to, afford to the
               officers, employees, accountants, counsel and other
               representatives of Buyer, access, during normal business
               hours during the period prior to the Effective Time, to
               all its properties, books, contracts, commitments,
               records, officers, employees, accountants, counsel and
               other representatives and, during such period, the
               Company shall, and shall cause its Subsidiaries to, make
               available to Buyer (i) a copy of each report, schedule,
               registration statement and other document filed or
               received by it during such period pursuant to the
               requirements of Federal securities laws or Federal or
               state banking laws (other than reports or documents which
               the Company is not permitted to disclose under applicable
               law) and (ii) all other information concerning its
               business, properties and personnel as Buyer may
               reasonably request.  Neither the Company nor any of its
               Subsidiaries shall be required to provide access to or to
               disclose information where such access or disclosure
               would violate or prejudice the rights of the Company's
               customers, jeopardize any attorney-client privilege or
               contravene any law, rule, regulation, order, judgment,
               decree, fiduciary duty or binding agreement entered into
               prior to the date of this Agreement.  The parties hereto
               will make appropriate substitute disclosure arrangements
               under circumstances in which the restrictions of the
               preceding sentence apply.  Buyer will hold all such
               information in confidence to the extent required by, and
               in accordance with, the provisions of the confidentiality
               agreement, dated May 5, 1993, between Buyer and the
               Company (the "Confidentiality Agreement").

                              (b)  Upon reasonable notice and subject to
               applicable laws relating to the exchange of information,
               Buyer shall, and shall cause its Subsidiaries to, afford
               to the officers, employees, accountants, counsel and
               other representatives of the Company, access, during
               normal business hours during the period prior to the
               Effective Time, to such information regarding Buyer and
               its Subsidiaries as shall be reasonably necessary for the
               Company to fulfill its obligations pursuant to this
               Agreement to prepare the Proxy Statement or which may be
               reasonably necessary for the Company to confirm that the
               representations and warranties of Buyer contained herein
               are true and correct and that the covenants of Buyer
               contained herein have been performed in all material
               respects.  Neither Buyer nor any of its Subsidiaries
               shall be required to provide access to or to disclose
               information where such access or disclosure would violate
               or prejudice the rights of Buyer's customers, jeopardize
               any attorney-client privilege or contravene any law,
               rule, regulation, order, judgment, decree, fiduciary duty
               or binding agreement entered into prior to the date of
               this Agreement.  The parties hereto will make appropriate
               substitute disclosure arrangements under circumstances in
               which the restrictions of the preceding sentence apply. 

                              (c)  All information furnished by Buyer to
               the Company or its representatives pursuant hereto shall
               be treated as the sole property of Buyer and, if the
               Merger shall not occur, the Company and its
               representatives shall return to Buyer all of such written
               information and all documents, notes, summaries or other
               materials containing, reflecting or referring to, or
               derived from, such information.  The Company shall, and
               shall use its best efforts to cause its representatives
               to, keep confidential all such information, and shall not
               directly or indirectly use such information for any
               competitive or other commercial purpose.  The obligation
               to keep such information confidential shall continue for
               five years from the date the proposed Merger is abandoned
               and shall not apply to (i) any information which (x) was
               already in the Company's possession prior to the
               disclosure thereof by Buyer; (y) was then generally known
               to the public; or (z) was disclosed to the Company by a
               third party not bound by an obligation of confidentiality
               or (ii) disclosures made as required by law.  It is
               further agreed that, if in the absence of a protective
               order or the receipt of a waiver hereunder the Company is
               nonetheless, in the opinion of its counsel, compelled to
               disclose information concerning Buyer to any tribunal or
               governmental body or agency or else stand liable for
               contempt or suffer other censure or penalty, the Company
               may disclose such information to such tribunal or
               governmental body or agency without liability hereunder.

                              (d)  No investigation by either of the
               parties or their respective representatives shall affect
               the representations, warranties, covenants or agreements
               of the other set forth herein.

                         6.3.  Stockholder Meetings.  The Company and
               Buyer each shall take all steps necessary to duly call,
               give notice of, convene and hold a meeting of its
               respective stockholders to be held as soon as is
               reasonably practicable after the date on which the S-4
               becomes effective for the purpose of voting upon the
               approval of this Agreement and the consummation of the
               transactions contemplated hereby.  The Company and Buyer
               each will, through its respective Board of Directors,
               except to the extent legally required for the discharge
               of the fiduciary duties of such board, recommend to its
               respective stockholders approval of this Agreement and
               the transactions contemplated hereby and such other
               matters as may be submitted to its stockholders in
               connection with this Agreement.  The Company and Buyer
               shall coordinate and cooperate with respect to the
               foregoing matters, with a view towards, among other
               things, holding the respective meetings of each party's
               stockholders on the same day.

                         6.4.  Legal Conditions to Merger.  Each of
               Buyer and the Company shall, and shall cause its
               Subsidiaries to, use their best efforts (a) to take, or
               cause to be taken, all actions necessary, proper or
               advisable to comply promptly with all legal requirements
               which may be imposed on such party or its Subsidiaries
               with respect to the Merger or the Subsidiary Merger and,
               subject to the conditions set forth in Article VII
               hereof, to consummate the transactions contemplated by
               this Agreement and (b) to obtain (and to cooperate with
               the other party to obtain) any consent, authorization,
               order or approval of, or any exemption by, any
               Governmental Entity and any other third party which is
               required to be obtained by the Company or Buyer or any of
               their respective Subsidiaries in connection with the
               Merger and the Subsidiary Merger and the other
               transactions contemplated by this Agreement, and to
               comply with the terms and conditions of such consent,
               authorization, order or approval; provided, however, that
               neither Buyer nor the Company shall be obligated to take
               any action pursuant to the foregoing if the taking of
               such action or such compliance or the obtaining of such
               consent, authorization, order or approval is likely, in
               the good faith reasonable opinion of Buyer or the
               Company, to result in the imposition of a Burdensome
               Condition.

                         6.5.  Affiliates.  Each of Buyer and the
               Company shall use its best efforts to cause each
               director, executive officer and other person who is an
               "affiliate" (for purposes of Rule 145 under the
               Securities Act and for purposes of qualifying the Merger
               for "pooling-of-interests" accounting treatment) of such
               party to deliver to the other party hereto, as soon as
               practicable after the date of this Agreement, and in any
               event prior to the earlier of the date of the
               stockholders meeting called by the Company to approve
               this Agreement and the date of the stockholders meeting
               called by Buyer to approve this Agreement, a written
               agreement, in the form of Exhibit 6.5(a) hereto (in the
               case of affiliates of Buyer) or 6.5(b) hereto (in the
               case of affiliates of the Company), providing that such
               person will not sell, pledge, transfer or otherwise
               dispose of any shares of Buyer Common Stock or Company
               Common Stock held by such "affiliate" and, in the case of
               the "affiliates" of the Company, the shares of Buyer
               Common Stock to be received by such "affiliate" in the
               Merger:  (1) in the case of shares of Buyer Common Stock
               to be received by "affiliates" of the Company in the
               Merger, except in compliance with the applicable
               provisions of the Securities Act and the rules and
               regulations thereunder; and (2) during the period
               commencing 30 days prior to the Merger and ending at the
               time of the publication of financial results covering at
               least 30 days of combined operations of Buyer and the
               Company.

                         6.6.  Stock Exchange Listing.  Buyer shall
               cause the shares of Buyer Common Stock to be issued in
               the Merger to be approved for listing on the New York
               Stock Exchange, Inc. (the "NYSE"), subject to official
               notice of issuance, as of the Effective Time.

                         6.7.  Employee Benefit Plans; Existing
               Agreements.  (a)  The employees of the Company (the
               "Company Employees") shall be entitled to participate in
               Buyer's employee benefit plans in which similarly
               situated employees of Buyer participate, to the same
               extent as comparable employees of Buyer.  As of the
               Effective Time, Buyer shall permit the Company Employees
               to participate in Buyer's group hospitalization, medical,
               life and disability insurance plans on the same terms and
               conditions as applicable to comparable employees of Buyer
               and its Subsidiaries.  As of the next entry date
               immediately following the Effective Time, Buyer shall
               permit the Company Employees to participate in Buyer's
               defined benefit pension plan, thrift plan, severance, and
               similar plans on the same terms and conditions as
               employees of Buyer and its Subsidiaries, giving effect
               (solely for purposes of Buyer's defined benefit pension
               plan and thrift plan) to years of service with the
               Company and its Subsidiaries (to the extent the Company
               gave effect) as if such service were with Buyer, for
               purposes of eligibility and vesting, but not for benefit
               accrual purposes.

                         (b)  Following the Effective Time, Buyer shall
               honor and shall cause the Surviving Bank to honor in
               accordance with their terms all employment, severance and
               other compensation agreements and arrangements,
               including, but not limited to, severance benefit plans
               listed in Section 6.7(b) of the Company Disclosure
               Schedule, existing prior to the execution of this
               Agreement which are between the Company and any director,
               officer or employee thereof and which have been disclosed
               in the Company Disclosure Schedule and previously have
               been delivered to Buyer and agrees to make the payments
               and provide the benefits pursuant thereto described in
               Section 6.7(b) of the Company Disclosure Schedule.

                         (c)  As of the Effective Time, Buyer will
               assume, or will cause New York Bank to assume, the tax
               qualified plans of the Company Bank as listed in Section
               3.11(a) of the Company Disclosure Schedule.  Neither
               Buyer nor New York Bank shall be required to make further
               contributions to such plans.  As of the Effective Time,
               all accrued benefits under the plans shall be fully
               vested and nonforfeitable.  As soon as practicable after
               the Effective Time, Buyer shall terminate or shall cause
               New York Bank to terminate the tax qualified plans of the
               Company Bank assumed by Buyer, or New York Bank, pursuant
               to this Section 6.7(c), and distribution of the accounts
               of active participants immediately prior to the Effective
               Time under the plans shall be made to the participants
               and beneficiaries in accordance with the terms of such
               plans.

                         (d)  From and after the date of this Agreement
               until the Effective Time, in anticipation of such
               termination and distribution, the Company and the Company
               Bank shall use their best efforts, and after the
               Effective Time, Buyer and New York Bank shall use their
               best efforts to take all necessary and appropriate action
               to cause unallocated Company Common Stock pledged as
               collateral for the loan made to the Company Bank Employee
               Stock Ownership Plan ("ESOP") to be applied to repay the
               outstanding securities acquisition loan, to allocate the
               amount of such stock with a value in excess of the
               balance of such loan to the accounts of the ESOP
               participants in proportion to their account balances at
               the Effective Time and to maintain the status of the ESOP
               as a plan qualified under Sections 401(a) and 4975 of the
               of the Code.  In the event that prior to the Effective
               Time, the Company or the Company Bank, or after the
               Effective Time, Buyer or New York Bank, determines that
               the loan may not be so repaid or that such amounts may
               not be so allocated without causing the ESOP to fail to
               be a tax qualified plan under Sections 401(a) and 4975 of
               the Code, the Company or the Company Bank before the
               Effective Time, and Buyer or New York Bank after the
               Effective Time, shall take such action as each may
               determine with respect to the ESOP, provided that the
               assets of the ESOP shall be held or paid for the
               exclusive benefit of the ESOP participants and
               beneficiaries, and provided further, in no event shall
               any portion of the amounts held in trust by the ESOP
               revert directly or indirectly to the Company, the Company
               Bank, Buyer or New York Bank or any affiliate thereof.

                         (e)  Following the Effective Time, Buyer shall
               honor and shall cause any successor corporation and its
               affiliates to honor in accordance with its terms, the
               Company Bank post retirement medical plan as listed in
               Section 6.7(e) of the Company Disclosure Schedule with
               respect to benefits being paid thereunder at the
               Effective Time, and benefits thereunder to those who
               would be eligible for such benefits at retirement as of
               the Effective Time.

                         (f)  Notwithstanding anything contained in an
               employment agreement or other compensation arrangement,
               or in this Agreement to the contrary, the Buyer shall
               provide benefits under the terms of the Company Bank post
               retirement medical plan to those employees listed in
               Section 6.7(f) of the Company Disclosure Schedule who
               terminate employment with the Company Bank after the
               Effective Time, provided that such benefits shall be
               continued for the lifetime of such employees' spouse in
               the event that any such employee predeceases the spouse.

                         (g)  Notwithstanding anything contained in this
               Agreement to the contrary, Buyer shall provide each
               employee listed in Section 6.7(g) of the Company
               Disclosure Schedule with the opportunity to continue
               medical/dental coverage under the Buyer's group policy
               upon payment by such employee of the cost of the premiums
               for such individual under the group policy for the
               remainder of the employee's life or the employee first
               obtains comparable benefits from another employer,
               whichever is earlier.

                         (h)  Following the Effective Time, Buyer shall
               provide continued medical/dental and life insurance
               benefits for each employee listed in Section 6.7(h) of
               the Company Disclosure Schedule, for a one year period
               following such individual's termination of employment
               with the Company Bank as provided in the Special
               Termination Agreements listed in Schedule 3.11(a).  In
               addition, Buyer shall provide each such individual with
               the opportunity to continue medical/dental insurance
               coverage upon payment by such employee of the cost of the
               premium for such individual under the group coverage of
               Buyer for a period of four years commencing on the first
               anniversary of the date of such individual's termination
               of employment, or, if sooner, the time the individual
               obtains comparable benefits through another employer.

                         6.8.  Indemnification.  (a)  In the event of
               any threatened or actual claim, action, suit, proceeding
               or investigation, whether civil, criminal or
               administrative, including, without limitation, any such
               claim, action, suit, proceeding or investigation in which
               any person who is now, or has been at any time prior to
               the date of this Agreement, or who becomes prior to the
               Effective Time, a director or officer or employee of the
               Company or any of its Subsidiaries (the "Indemnified
               Parties") is, or is threatened to be, made a party based
               in whole or in part on, or arising in whole or in part
               out of, or pertaining to (i) the fact that he is or was a
               director, officer or employee of the Company, any of the
               Subsidiaries of the Company or any of their respective
               predecessors or (ii) this Agreement or any of the
               transactions contemplated hereby, whether in any case
               asserted or arising before or after the Effective Time,
               the parties hereto agree to cooperate and use their best
               efforts to defend against and respond thereto.  It is
               understood and agreed that after the Effective Time,
               Buyer shall indemnify and hold harmless, as and to the
               extent permitted by Delaware law, each such Indemnified
               Party against any losses, claims, damages, liabilities,
               costs, expenses (including reasonable attorney's fees and
               expenses in advance of the final disposition of any
               claim, suit, proceeding or investigation to each
               Indemnified Party to the fullest extent permitted by law
               upon receipt of any undertaking required by applicable
               law), judgments, fines and amounts paid in settlement in
               connection with any such threatened or actual claim,
               action, suit, proceeding or investigation, and in the
               event of any such threatened or actual claim, action,
               suit, proceeding or investigation (whether asserted or
               arising before or after the Effective Time), the
               Indemnified Parties may retain counsel reasonably
               satisfactory to them after consultation with Buyer;
               provided, however, that (1) Buyer shall have the right to
               assume the defense thereof and upon such assumption Buyer
               shall not be liable to any Indemnified Party for any
               legal expenses of other counsel or any other expenses
               subsequently incurred by any Indemnified Party in
               connection with the defense thereof, except that if Buyer
               elects not to assume such defense or counsel for the
               Indemnified Parties reasonably advises that there are
               issues which raise conflicts of interest between Buyer
               and the Indemnified Parties, the Indemnified Parties may
               retain counsel reasonably satisfactory to them after
               consultation with Buyer, and Buyer shall pay the
               reasonable fees and expenses of such counsel for the
               Indemnified Parties, (2) Buyer shall in all cases be
               obligated pursuant to this paragraph to pay for only one
               firm of counsel for all Indemnified Parties, (3) Buyer
               shall not be liable for any settlement effected without
               its prior written consent (which consent shall not be
               unreasonably withheld) and (4) Buyer shall have no
               obligation hereunder to any Indemnified Party when and if
               a court of competent jurisdiction shall ultimately
               determine, and such determination shall have become final
               and nonappealable, that indemnification of such
               Indemnified Party in the manner contemplated hereby is
               prohibited by applicable law.  Any Indemnified Party
               wishing to claim Indemnification under this Section 6.8,
               upon learning of any such claim, action, suit, proceeding
               or investigation, shall notify promptly Buyer thereof,
               provided that the failure to so notify shall not affect
               the obligations of Buyer under this Section 6.8 except to
               the extent such failure to notify prejudices Buyer. 
               Buyer's obligations under this Section 6.8 continue in
               full force and effect for a period of six (6) years from
               the Effective Time; provided, however, that all rights to
               indemnification in respect of any claim (a "Claim")
               asserted or made within such period shall continue until
               the final disposition of such Claim.  Notwithstanding
               anything to the contrary contained in this Section
               6.8(a), in no event shall Buyer's obligations under this
               Section 6.8(a) with respect to indemnification or the
               advancement of expenses be greater than the obligations
               of the Company and its Subsidiaries with respect thereto
               set forth as of the date of this Agreement in the
               Certificate of Incorporation, By-laws or similar
               governing documents of the Company and its Subsidiaries.

                              (b)  Buyer shall cause the persons serving
               as officers and directors of the Company immediately
               prior to the Effective Time to be covered for a period of
               four years from the Effective Time by the directors' and
               officers' liability insurance policy maintained by the
               Company (provided that Buyer may substitute therefor
               policies of at least the same coverage and amounts
               containing terms and conditions which are not less
               advantageous than such policy) with respect to acts or
               omissions occurring prior to the Effective Time which
               were committed by such officers and directors in their
               capacity as such; provided, however, that such policy
               shall be increased to an amount of at least $3,000,000.

                              (c)  In the event Buyer or the Surviving
               Corporation or any of its successors or assigns (i)
               consolidates with or merges into any other person and
               shall not be the continuing or surviving corporation or
               entity of such consolidation or merger, or (ii) transfers
               or conveys all or substantially all of its properties and
               assets to any person, then, and in each such case, to the
               extent necessary, proper provision shall be made so that
               the successors and assigns of Buyer or the Surviving
               Corporation, as the case may be, assume the obligations
               set forth in this section.

                              (d)  The provisions of this Section 6.8
               are intended to be for the benefit of, and shall be
               enforceable by, each Indemnified Party and his or her
               heirs and representatives.

                         6.9.  Subsequent Interim and Annual Financial
               Statements.  As soon as reasonably available, but in no
               event later than March 31, 1995 or, in the case of the
               Company, December 31, 1994, Buyer will deliver to the
               Company and the Company will deliver to Buyer their
               respective Annual Reports on Form 10-K for, in the case
               of Buyer, the fiscal year ended December 31, 1994 and, in
               the case of the Company, the fiscal year ended September
               30, 1994, as filed with the SEC under the Exchange Act. 
               As soon as reasonably available, but in no event more
               than 45 days after the end of each fiscal quarter ending
               after the date of this Agreement, Buyer will deliver to
               the Company and the Company will deliver to Buyer their
               respective Quarterly Reports on Form 10-Q, as filed with
               the SEC under the Exchange Act.

                         6.10.  Additional Agreements.  In case at any
               time after the Effective Time any further action is
               necessary or desirable to carry out the purposes of this
               Agreement, or the Bank Merger Agreement, or to vest the
               Surviving Corporation or the Surviving Bank with full
               title to all properties, assets, rights, approvals,
               immunities and franchises of any of the parties to the
               Merger or the Subsidiary Merger, the proper officers and
               directors of each party to this Agreement and their
               respective Subsidiaries shall take all such necessary
               action as may be reasonably requested by Buyer.

                         6.11.  Advice of Changes.  Buyer and the
               Company shall promptly advise the other party of any
               change or event having a Material Adverse Effect on it or
               which it believes would or would be reasonably likely to
               cause or constitute a material breach of any of its
               representations, warranties or covenants contained
               herein.  From time to time prior to the Effective Time
               (and on the date prior to the Closing Date), each party
               will promptly supplement or amend the Disclosure
               Schedules delivered in connection with the execution of
               this Agreement to reflect any matter which, if existing,
               occurring or known at the date of this Agreement, would
               have been required to be set forth or described in such
               Disclosure Schedules or which is necessary to correct any
               information in such Disclosure Schedules which has been
               rendered inaccurate thereby.  No supplement or amendment
               to such Disclosure Schedules shall have any effect for
               the purpose of determining satisfaction of the conditions
               set forth in Sections 7.2(a) or 7.3(a) hereof, as the
               case may be, or the compliance by the Company or Buyer,
               as the case may be, with the respective covenants and
               agreements of such parties contained herein.

                         6.12.  Current Information.  During the period
               from the date of this Agreement to the Effective Time,
               the Company will cause one or more of its designated
               representatives to confer on a regular and frequent basis
               (not less than monthly) with representatives of Buyer and
               to report (i) the general status of the ongoing
               operations of the Company and its Subsidiaries and (ii)
               the status of, and the action proposed to be taken with
               respect to, those Loans held by the Company or any
               Subsidiary of the Company which, individually or in
               combination with one or more other Loans to the same
               borrower thereunder, have an original principal amount of
               $250,000 or more and are non-performing assets.  The
               Company will promptly notify Buyer of any material change
               in the normal course of business or in the operation of
               the properties of the Company or any of its Subsidiaries
               and of any governmental complaints, investigations or
               hearings (or communications indicating that the same may
               be contemplated), or the institution or the threat of
               significant litigation involving the Company or any of
               its Subsidiaries, and will keep Buyer fully informed of
               such events.

                         6.13.  Execution and Authorization of Bank
               Merger Agreement.  As soon as reasonably practicable
               after the date of this Agreement, (a) Buyer shall (i)
               cause the Board of Directors of New York Bank to approve
               the Bank Merger Agreement, (ii) cause New York Bank to
               execute and deliver the Bank Merger Agreement, and (iii)
               approve the Bank Merger Agreement as the sole stockholder
               of New York Bank, and (b) the Company shall (i) cause the
               Board of Directors of the Company Bank to approve the
               Bank Merger Agreement, (ii) cause the Company Bank to
               execute and deliver the Bank Merger Agreement, and (iii)
               approve the Bank Merger Agreement as the sole stockholder
               of the Company Bank.  The Bank Merger Agreement shall
               contain terms that are normal and customary in light of
               the transactions contemplated hereby and such additional
               terms as are necessary to carry out the purposes of this
               Agreement.  If Buyer, upon the advice of its counsel,
               determines that there is a reasonable possibility that
               the Subsidiary Merger is not legally permissible under
               the laws of the State of New York or will not be approved
               by the Banking Department as a result of Company's status
               as a federal savings bank, Buyer shall notify the Company
               accordingly and the Company shall, subject to the
               requirements of applicable law, use its best efforts to
               cause the Company Bank to be converted to a New York
               chartered savings bank (the "Conversion") as soon as
               practicable after the Company's receipt of such notice
               from Buyer (but in no event prior to the day immediately
               prior to the Effective Time), and, subject to the terms
               and conditions hereof, both Buyer and the Company shall
               use their best efforts to cause such New York chartered
               savings bank to be merged with and into New York Bank
               with New York Bank surviving such merger, as soon as
               practicable after the Effective Time.

                         6.14.  Directorships.  Buyer shall cause its
               Board of Directors to be expanded by one member and shall
               appoint one of the current directors of the Company 
               selected by Buyer as a nominee to fill the vacancy on
               Buyer's Board of Directors created by such increase as of
               the Effective Time.

                                      ARTICLE VII

                                  CONDITIONS PRECEDENT

                         7.1.  Conditions to Each Party's Obligation To
               Effect the Merger.  The respective obligation of each
               party to effect the Merger shall be subject to the
               satisfaction at or prior to the Effective Time of the
               following conditions:

                              (a)  Stockholder Approval.  This Agreement
               shall have been approved and adopted by the affirmative
               vote of the holders of at least a majority of the
               outstanding shares of Company Common Stock entitled to
               vote thereon and by the affirmative vote of the holders
               of at least a majority of the outstanding shares of Buyer
               Common Stock entitled to vote thereon.

                              (b)  NYSE Listing.  The shares of Buyer
               Common Stock which shall be issued to the stockholders of
               the Company upon consummation of the Merger shall have
               been authorized for listing on the NYSE, subject to
               official notice of issuance.

                              (c)  Other Approvals.  All regulatory
               approvals required to consummate the transactions
               contemplated hereby (including the Merger, the Subsidiary
               Merger and, if necessary to consummate the Subsidiary
               Merger, the Conversion) shall have been obtained and
               shall remain in full force and effect and all statutory
               waiting periods in respect thereof shall have expired
               (all such approvals and the expiration of all such
               waiting periods being referred to herein as the
               "Requisite Regulatory Approvals").

                              (d)  S-4.  The S-4 shall have become
               effective under the Securities Act and no stop order
               suspending the effectiveness of the S-4 shall have been
               issued and no proceedings for that purpose shall have
               been initiated or threatened by the SEC.

                              (e)  No Injunctions or Restraints;
               Illegality.  No order, injunction or decree issued by any
               court or agency of competent jurisdiction or other legal
               restraint or prohibition (an "Injunction") preventing the
               consummation of the Merger, the Subsidiary Merger or any
               of the other transactions contemplated by this Agreement
               or the Bank Merger Agreement shall be in effect.  No
               statute, rule, regulation, order, injunction or decree
               shall have been enacted, entered, promulgated or enforced
               by any Governmental Entity which prohibits, restricts or
               makes illegal consummation of the Merger or the
               Subsidiary Merger.

                         7.2.  Conditions to Obligations of Buyer.  The
               obligation of Buyer to effect the Merger is also subject
               to the satisfaction or waiver by Buyer at or prior to the
               Effective Time of the following conditions:

                              (a)  Representations and Warranties.  (I) 
               The representations and warranties of the Company set
               forth in this Agreement shall be true and correct in all
               material respects as of the date of this Agreement and
               (except to the extent such representations and warranties
               speak as of an earlier date) as of the Closing Date as
               though made on and as of the Closing Date; and (II) the
               representations and warranties of the Company set forth
               in this Agreement shall be true and correct in all
               material respects as of the date of this Agreement and
               (except to the extent such representations and warranties
               speak as of an earlier date) as of the Closing Date as
               though made on and as of the Closing Date; provided,
               however, that for purposes of determining the
               satisfaction of the condition contained in this clause
               (II), no effect shall be given to any exception in such
               representations and warranties relating to materiality or
               a Material Adverse Effect, and provided, further,
               however, that, for purposes of this clause (II), such
               representations and warranties shall be deemed to be true
               and correct in all material respects unless the failure
               or failures of such representations and warranties to be
               so true and correct, individually or in the aggregate,
               represent a material adverse change from the business,
               assets, financial condition or results of operations of
               the Company and its Subsidiaries taken as a whole as
               represented herein.  Buyer shall have received a
               certificate signed on behalf of the Company by the Chief
               Executive Officer and the Chief Financial Officer of the
               Company to the foregoing effect.

                              (b)  Performance of Obligations of the
               Company.  The Company shall have performed in all
               material respects all obligations required to be
               performed by it under this Agreement at or prior to the
               Closing Date, and Buyer shall have received a certificate
               signed on behalf of the Company by the Chief Executive
               Officer and the Chief Financial Officer of the Company to
               such effect.

                              (c)  No Burdensome Condition.  None of the
               Requisite Regulatory Approvals shall impose any term,
               condition or restriction upon Buyer, the Company, the
               Company Bank, the Surviving Corporation, the Surviving
               Bank or any of their respective Subsidiaries that Buyer
               or the Company, in good faith, reasonably determines
               would so materially adversely affect the economic or
               business benefits of the transactions contemplated by
               this Agreement to Buyer or the Company as to render
               inadvisable in the reasonable good faith judgment of
               Buyer or the Company, the consummation of the Merger (a
               "Burdensome Condition").

                              (d)  Consents Under Agreements.  The
               consent, approval or waiver of each person (other than
               the Governmental Entities referred to in Section 7.1(c))
               whose consent or approval shall be required in order to
               permit the succession by the Surviving Corporation or the
               Surviving Bank pursuant to the Merger or the Subsidiary
               Merger, as the case may be, to any obligation, right or
               interest of the Company or any Subsidiary of the Company
               under any loan or credit agreement, note, mortgage,
               indenture, lease, license or other agreement or
               instrument shall have been obtained, except where the
               failure to obtain such consent, approval or waiver would
               not so  materially adversely affect the economic or
               business benefits of the transactions contemplated by
               this Agreement to Buyer as to render inadvisable, in the
               reasonable good faith judgment of Buyer, the consummation
               of the Merger.

                              (e)  No Pending Governmental Actions.  No
               proceeding initiated by any Governmental Entity seeking
               an Injunction shall be pending.

                              (f)  Federal Tax Opinion.  Buyer shall
               have received an opinion of Skadden, Arps, Slate, Meagher
               & Flom, counsel to Buyer ("Buyer's Counsel"), in form and
               substance reasonably satisfactory to Buyer, substantially
               to the effect that, on the basis of facts,
               representations and assumptions set forth in such opinion
               which are consistent with the state of facts existing at
               the Effective Time, the Merger and Subsidiary Merger will
               be treated as reorganizations within the meaning of
               Section 368(a) of the Code and that, accordingly, for
               federal income tax purposes no gain or loss will be
               recognized by Buyer, the Company, New York Bank or the
               Company Bank as a result of the Merger and Subsidiary
               Merger except to the extent the Company Bank or New York
               Bank may be required to recognize income due to the
               recapture of bad debt reserves as a result of the
               Subsidiary Merger.  In rendering such opinion, Buyer's
               Counsel may require and rely upon representations and
               covenants contained in certificates of officers of Buyer,
               the Company and others.

                              (g)  Legal Opinion.  Buyer shall have
               received the opinion of Muldoon, Murphy & Faucette,
               counsel to the Company (the "Company's Counsel"), dated
               the Closing Date, substantially in the form attached
               hereto as Exhibit 7.2(g).  As to any matter in such
               opinion which involves matters of fact or matters
               relating to laws other than Federal securities or
               Delaware corporate law, such counsel may rely upon the
               certificates of officers and directors of the Company and
               of public officials and opinions of local counsel,
               reasonably acceptable to Buyer, provided a copy of such
               reliance opinion shall be attached as an exhibit to the
               opinion of such counsel.

                              (h)  Pooling of Interests.  Buyer shall
               have received a letter from KPMG Peat Marwick addressed
               to Buyer, to the effect that the Merger will qualify for
               "pooling of interests" accounting treatment, unless such
               firm advises Buyer that it is unable to issue a letter to
               such effect solely by reason of Buyer having exercised
               its right to purchase Company Common Stock pursuant to
               the Option Agreement.

                              (i)  Accountant's Letter.  The Company
               shall have caused to be delivered to Buyer letters from
               KPMG Peat Marwick, independent public accountants with
               respect to the Company, dated the date on which the
               Registration Statement or last amendment thereto shall
               become effective, and dated the date of the Closing, and
               addressed to Buyer, with respect to the Company's
               consolidated financial position and results of
               operations, which letters shall be based upon agreed upon
               procedures to be specified by Buyer, which procedures
               shall be consistent with applicable professional
               standards for letters delivered by independent
               accountants in connection with comparable transactions.

                              (j)  Subsidiary Merger.  Nothing shall
               have come to the attention of Buyer which would preclude
               consummation of the Subsidiary Merger immediately
               following consummation of the Merger.

                         7.3.  Conditions to Obligations of the Company. 
               The obligation of the Company to effect the Merger is
               also subject to the satisfaction or waiver by the Company
               at or prior to the Effective Time of the following
               conditions: 

                              (a)  Representations and Warranties.  (I) 
               The representations and warranties of Buyer set forth in
               this Agreement shall be true and correct in all material
               respects as of the date of this Agreement and (except to
               the extent such representations and warranties speak as
               of an earlier date) as of the Closing Date as though made
               on and as of the Closing Date; and (II) the
               representations and warranties of Buyer set forth in this
               Agreement shall be true and correct in all material
               respects as of the date of this Agreement and (except to
               the extent such representations and warranties speak as
               of an earlier date) as of the Closing Date as though made
               on and as of the Closing Date; provided, however, that
               for purposes of determining the satisfaction of the
               condition contained in this clause (II), no effect shall
               be given to any exception in such representations and
               warranties relating to materiality or a Material Adverse
               Effect, and provided, further, however, that, for
               purposes of this clause (II), such representations and
               warranties shall be deemed to be true and correct in all
               material respects unless the failure or failures of such
               representations and warranties to be so true and correct,
               individually or in the aggregate, represent a material
               adverse change from the business, assets, financial
               condition or results of operations of Buyer and its
               Subsidiaries taken as a whole as represented herein.  The
               Company shall have received a certificate signed on
               behalf of Buyer by the Chief Executive Officer and the
               Chief Financial Officer of Buyer to the foregoing effect.

                              (b)  Performance of Obligations of Buyer. 
               Buyer shall have performed in all material respects all
               obligations required to be performed by it under this
               Agreement at or prior to the Closing Date, and the
               Company shall have received a certificate signed on
               behalf of Buyer by the Chief Executive Officer and the
               Chief Financial Officer of Buyer to such effect.

                              (c)  Consents Under Agreements.  The
               consent, approval or waiver of each person (other than
               the Governmental Entities referred to in Section 7.1(c))
               whose consent or approval shall be required in connection
               with the transactions contemplated hereby under any loan
               or credit agreement, note, mortgage, indenture, lease,
               license or other agreement or instrument to which Buyer
               or any of its Subsidiaries is a party or is otherwise
               bound, except those for which failure to obtain such
               consents and approvals would not, individually or in the
               aggregate, have a material adverse effect on the
               business, operations or financial condition of Buyer and
               its Subsidiaries taken as a whole (after giving effect to
               the transactions contemplated hereby), shall have been
               obtained.

                              (d)  No Pending Governmental Actions.  No
               proceeding initiated by any Governmental Entity seeking
               an Injunction shall be pending.

                              (e)  Federal Tax Opinion.  The Company
               shall have received an opinion of the Company's Counsel,
               in form and substance reasonably satisfactory to the
               Company, dated as of the Effective Time, substantially to
               the effect that, on the basis of facts, representations
               and assumptions set forth in such opinion which are
               consistent with the state of facts existing at the
               Effective Time, the Merger and the Subsidiary Merger will
               be treated as reorganizations within the meaning of
               Section 368(a) of the Code and that accordingly for
               federal income tax purposes:

                              (i)  No gain or loss will be
                    recognized by the Company as a result of the
                    Merger;

                              (ii)  No gain or loss will be
                    recognized by the Company Bank as a result of
                    the Subsidiary Merger except to the extent the
                    Company Bank or New York Bank may be required
                    to recognize income due to the recapture of bad
                    debt reserves as a result of the Subsidiary
                    Merger.

                              (iii)  No gain or loss will be
                    recognized by the shareholders of the Company
                    who exchange all of their Company Common Stock
                    solely for Buyer Common Stock pursuant to the
                    Merger (except with respect to cash received in
                    lieu of a fractional share interest in Buyer
                    Common Stock);

                              (iv)  The aggregate tax basis of the
                    Buyer Common Stock received by shareholders who
                    exchange all of their Company Common Stock
                    solely for Common Stock pursuant to the Merger
                    will be the same as the aggregate tax basis of
                    the Company Common Stock surrendered in
                    exchange therefor (reduced by any amount
                    allocable to a fractional share interest for
                    which cash is received).

               In rendering such opinion, the Company's Counsel may
               require and rely upon representations and covenants
               contained in certificates of officers of Buyer, the
               Company and others, including certain shareholders of the
               Company.

                              (f)  Legal Opinion.  The Company shall
               have received the opinion of Buyer's Counsel, dated the
               Closing Date, substantially in the form attached hereto
               as Exhibit 7.3(f).  As to any matter in such opinion
               which involves matters of fact or matters relating to
               laws other than Federal securities law or Delaware
               corporate law, such counsel may rely upon the
               certificates of officers and directors of Buyer and of
               public officials and opinions of local counsel,
               reasonably acceptable to the Company, provided a copy of
               such reliance opinions shall be attached as an exhibit to
               the opinion of such counsel.

                                      ARTICLE VIII

                               TERMINATION AND AMENDMENT

                         8.1.  Termination.  This Agreement may be
               terminated at any time prior to the Effective Time,
               whether before or after approval of the matters presented
               in connection with the Merger by the stockholders of both
               the Company and Buyer:

                              (a)  by mutual consent of the Company and
               Buyer in a written instrument, if the Board of Directors
               of each so determines by a vote of a majority of the
               members of its entire Board;

                              (b)  by either Buyer or the Company upon
               written notice to the other party (i) 60 days after the
               date on which any request or application for a Requisite
               Regulatory Approval shall have been denied or withdrawn
               at the request or recommendation of the Governmental
               Entity which must grant such Requisite Regulatory
               Approval, unless within the 60-day period following such
               denial or withdrawal a petition for rehearing or an
               amended application has been filed with the applicable
               Governmental Entity, provided, however, that no party
               shall have the right to terminate this Agreement pursuant
               to this Section 8.1(b)(i) if such denial or request or
               recommendation for withdrawal shall be due to the failure
               of the party seeking to terminate this Agreement to
               perform or observe the covenants and agreements of such
               party set forth herein or (ii) if any Governmental Entity
               of competent jurisdiction shall have issued a final
               nonappealable order enjoining or otherwise prohibiting
               the consummation of any of the transactions contemplated
               by this Agreement;

                              (c)  by either Buyer or the Company if the
               Merger shall not have been consummated on or before June
               30, 1995, unless the failure of the Closing to occur by
               such date shall be due to the failure of the party
               seeking to terminate this Agreement to perform or observe
               the covenants and agreements of such party set forth
               herein;

                              (d)  by either Buyer or the Company
               (provided that the terminating party shall not be in
               material breach of any of its obligations under Section
               6.3) if any approval of the stockholders of either of the
               Company or Buyer required for the consummation of the
               Merger shall not have been obtained by reason of the
               failure to obtain the required vote at a duly held
               meeting of such stockholders or at any adjournment or
               postponement thereof;

                              (e)  by either Buyer or the Company
               (provided that the terminating party is not then in
               material breach of any representation, warranty, covenant
               or other agreement contained herein) if there shall have
               been a material breach of any of the representations or
               warranties set forth in this Agreement on the part of the
               other party, which breach is not cured within thirty days
               following written notice to the party committing such
               breach, or which breach, by its nature, cannot be cured
               prior to the Closing; provided, however, that neither
               party shall have the right to terminate this Agreement
               pursuant to this Section 8.1(e) unless the breach of
               representation or warranty, together with all other such
               breaches, would entitle the party receiving such
               representation not to consummate the transactions
               contemplated hereby under Section 7.2(a) (in the case of
               a breach of representation or warranty by the Company) or
               Section 7.3(a) (in the case of a breach of representation
               or warranty by Buyer);

                              (f)  by either Buyer or the Company
               (provided that the terminating party is not then in
               material breach of any representation, warranty, covenant
               or other agreement contained herein) if there shall have
               been a material breach of any of the covenants or
               agreements set forth in this Agreement on the part of the
               other party, which breach shall not have been cured
               within thirty days following receipt by the breaching
               party of written notice of such breach from the other
               party hereto;

                              (g)  by the Company, by action of its
               Board of Directors, whether before or after approval of
               the Merger by the Company's stockholders, by giving
               written notice of such election to Buyer within two NYSE
               trading days after the Valuation Period in the event the
               Average Closing Price is less than $12.50 per share;
               provided, however, that no right of termination shall
               arise under this Section 8.1(g) if Buyer elects within 5
               business days of receipt of such written notice to notify
               the Company in writing that it has waived its right to
               utilize the Maximum Exchange Ratio and has increased the
               Exchange Ratio such that the value of the consideration
               (valued at the Average Closing Price) to be paid in
               respect of each share of Company Common Stock to be
               converted into Buyer Common Stock and cash in lieu of
               fractional shares upon consummation of the Merger is
               $21.99 per share;

                              (h)  by Buyer, if the Board of Directors
               of the Company does not publicly recommend in the Proxy
               Statement that the Company's stockholders approve and
               adopt this Agreement or if, after recommending in the
               Proxy Statement that stockholders approve and adopt this
               Agreement, the Board of Directors of the Company shall
               have withdrawn, modified or amended such recommendation
               in any respect materially adverse to Buyer;

                              (i)  By the Company, if on or prior to the
               close of business on the 30th day following the execution
               of this Agreement, the Company reasonably determines in
               good faith that the business or financial condition of
               Buyer and its Subsidiaries taken as a whole has
               materially and adversely changed from that described in
               Buyer's Annual Report on Form 10-K for the fiscal year
               ended on December 31,1993; or

                              (j)  by Buyer, after the thirtieth and
               prior to the close of business on the sixtieth day
               following the date of this Agreement, if within thirty
               days after the date of this Agreement, the Company shall
               not have obtained all of the consents referred to in
               Section 1.5 hereof.

                              8.2.  Effect of Termination; Expenses.  In
               the event of termination of this Agreement by either
               Buyer or the Company as provided in Section 8.1, this
               Agreement shall forthwith become void and have no effect
               except (i) the last sentence of Section 6.2(a), and
               Sections 6.2(c), 8.2 and 9.4, shall survive any
               termination of this Agreement, (ii) that notwithstanding
               anything to the contrary contained in this Agreement, no
               party shall be relieved or released from any liabilities
               or damages arising out of its willful breach of any
               provision of this Agreement, and (iii) in the event this
               Agreement (x) is terminated subsequent to the occurrence
               of a Purchase Event (as such term is defined in the
               Option Agreement) or (y) is terminated by Buyer pursuant
               to Section 8.1(f) hereof, and within 12 months after such
               termination by Buyer pursuant to Section 8.1(f) hereof a
               Purchase Event shall occur, then in addition to any other
               amounts payable or stock issuable by the Company pursuant
               to this Agreement or the Option Agreement, as the case
               may be, the Company shall pay to Buyer a termination fee
               of $2,000,000.  

                         8.3.  Amendment.  Subject to compliance with
               applicable law, this Agreement may be amended by the
               parties hereto, by action taken or authorized by their
               respective Boards of Directors, at any time before or
               after approval of the matters presented in connection
               with the Merger by the stockholders of either the Company
               or Buyer; provided, however, that after any approval of
               the transactions contemplated by this Agreement by the
               Company's stockholders, there may not be, without further
               approval of such stockholders, any amendment of this
               Agreement which reduces the amount or changes the form of
               the consideration to be delivered to the Company
               stockholders hereunder other than as contemplated by this
               Agreement.  This Agreement may not be amended except by
               an instrument in writing signed on behalf of each of the
               parties hereto.

                         8.4.  Extension; Waiver.  At any time prior to
               the Effective Time, the parties hereto, by action taken
               or authorized by their respective Board of Directors,
               may, to the extent legally allowed, (a) extend the time
               for the performance of any of the obligations or other
               acts of the other parties hereto, (b) waive any
               inaccuracies in the representations and warranties
               contained herein or in any document delivered pursuant
               hereto and (c) waive compliance with any of the
               agreements or conditions contained herein.  Any agreement
               on the part of a party hereto to any such extension or
               waiver shall be valid only if set forth in a written
               instrument signed on behalf of such party, but such
               extension or waiver or failure to insist on strict
               compliance with an obligation, covenant, agreement or
               condition shall not operate as a waiver of, or estoppel
               with respect to, any subsequent or other failure.

                                       ARTICLE IX

                                   GENERAL PROVISIONS

                         9.1.  Closing.  Subject to the terms and
               conditions of this Agreement and the Bank Merger
               Agreement, the closing of the Merger (the "Closing") will
               take place at 10:00 a.m. on a date to be specified by the
               parties, which shall be the first day which is (a) the
               last business day of a month and (b) at least two
               business days after the satisfaction or waiver (subject
               to applicable law) of the latest to occur of the
               conditions set forth in Article VII hereof (the "Closing
               Date"), at the offices of Buyer's Counsel unless another
               time, date or place is agreed to in writing by the
               parties hereto.

                         9.2.  Alternative Structure.  Notwithstanding
               anything to the contrary contained in this Agreement,
               subject to the Company's consent, which consent shall not
               be unreasonably withheld, prior to the Effective Time,
               Buyer shall be entitled to revise the structure of the
               Merger and/or the Subsidiary Merger and related
               transactions provided that each of the transactions
               comprising such revised structure shall (i) fully qualify
               as, or fully be treated as part of, one or more tax-free
               reorganizations within the meaning of Section 368(a) of
               the Code, and not subject any of the stockholders of the
               Company to adverse tax consequences or change the amount
               of consideration to be received by such stockholders,
               (ii) be properly treated for financial reporting purposes
               as a pooling of interests, (iii) be capable of
               consummation in as timely a manner as the structure
               contemplated herein and (iv) not otherwise be prejudicial
               to the interests of the stockholders of the Company. 
               This Agreement and any related documents shall be
               appropriately amended in order to reflect any such
               revised structure.

                         9.3.  Nonsurvival of Representations,
               Warranties and Agreements.  None of the representations,
               warranties, covenants and agreements in this Agreement or
               in any instrument delivered pursuant to this Agreement
               (other than pursuant to the Option Agreement, which shall
               terminate in accordance with its terms) shall survive the
               Effective Time, except for those covenants and agreements
               contained herein and therein which by their terms apply
               in whole or in part after the Effective Time.

                         9.4.  Expenses.  All costs and expenses
               incurred in connection with this Agreement and the
               transactions contemplated hereby shall be paid by the
               party incurring such expense, provided, however, that the
               costs and expenses of printing and mailing the Proxy
               Statement to the stockholders of the Company and Buyer,
               and all filing and other fees paid to the SEC or any
               other Governmental Entity in connection with the Merger,
               the Subsidiary Merger and the other transactions
               contemplated hereby, shall be borne equally by Buyer and
               the Company, provided, further, however, that nothing
               contained herein shall limit either party's rights to
               recover any liabilities or damages arising out of the
               other party's willful breach of any provision of this
               Agreement.

                         9.5.  Notices.  All notices and other
               communications hereunder shall be in writing and shall be
               deemed given if delivered personally, telecopied (with
               confirmation), mailed by registered or certified mail
               (return receipt requested) or delivered by an express
               courier (with confirmation) to the parties at the
               following addresses (or at such other address for a party
               as shall be specified by like notice):

                              (a)  if to Buyer, to:

                                   North Fork Bancorporation, Inc.
                                   9025 Route 25
                                   Mattituck, N.Y.  11952
                                   Attention:  Chief Executive Officer

                                   with a copy to:

                                   Skadden, Arps Slate, Meagher & Flom
                                   919 Third Avenue
                                   New York, New York 10022
                                   Attn:  Fred B. White, III, Esq.

                    and


                              (b)  if to the Company, to:

                                   Metro Bancshares Inc.
                                   100 Jericho Quadrangle
                                   Jericho, N.Y.  11753
                                   Attention:  Chief Executive Officer

                                   with a copy to:

                                   Muldoon, Murphy & Faucette
                                   501 Wisconsin Avenue NW
                                   Suite 508
                                   Washington, D.C. 20016
                                   Attn:  Joe Passaic, Esq.

                         9.6.  Interpretation.  When a reference is made
               in this Agreement to Sections, Exhibits or Schedules,
               such reference shall be to a Section of or Exhibit or
               Schedule to this Agreement unless otherwise indicated.
               The table of contents and headings contained in this
               Agreement are for reference purposes only and shall not
               affect in any way the meaning or interpretation of this
               Agreement.  Whenever the words "include", "includes" or
               "including" are used in this Agreement, they shall be
               deemed to be followed by the words "without limitation". 
               The phrases "the date of this Agreement", "the date
               hereof" and terms of similar import, unless the context
               otherwise requires, shall be deemed to refer to June 27,
               1994.

                         9.7.  Counterparts.  This Agreement may be
               executed in counterparts, all of which shall be
               considered one and the same agreement and shall become
               effective when counterparts have been signed by each of
               the parties and delivered to the other parties, it being
               understood that all parties need not sign the same
               counterpart.

                         9.8.  Entire Agreement.  This Agreement
               (including the documents and the instruments referred to
               herein) constitutes the entire agreement and supersedes
               all prior agreements and understandings, both written and
               oral, among the parties with respect to the subject
               matter hereof, other than the Confidentiality Agreement,
               the Bank Merger Agreement and the Option Agreement.   

                         9.9.  Governing Law.  This Agreement shall be
               governed and construed in accordance with the laws of the
               State of Delaware, without regard to any applicable
               conflicts of law.

                         9.10.  Enforcement of Agreement.  The parties
               hereto agree that irreparable damage would occur in the
               event that the provisions contained in the last sentence
               of Section 6.2(a) and in Section 6.2(c) of this Agreement
               were not performed in accordance with its specific terms
               or was otherwise breached.  It is accordingly agreed that
               the parties shall be entitled to an injunction or
               injunctions to prevent breaches of the last sentence of
               Section 6.2(a) and Section 6.2(c) of this Agreement and
               to enforce specifically the terms and provisions thereof
               in any court of the United States or any state having
               jurisdiction, this being in addition to any other remedy
               to which they are entitled at law or in equity.

                         9.11.  Severability.  Any term or provision of
               this Agreement which is invalid or unenforceable in any
               jurisdiction shall, as to that jurisdiction, be
               ineffective to the extent of such invalidity or
               unenforceability without rendering invalid or
               unenforceable the remaining terms and provisions of this
               Agreement or affecting the validity or enforceability of
               any of the terms or provisions of this Agreement in any
               other jurisdiction.  If any provision of this Agreement
               is so broad as to be unenforceable, the provision shall
               be interpreted to be only so broad as is enforceable.

                         9.12.  Publicity.  Except as otherwise required
               by law or the rules of the NYSE or the American Stock
               Exchange, so long as this Agreement is in effect, neither
               Buyer nor the Company shall, or shall permit any of its
               Subsidiaries to, issue or cause the publication of any
               press release or other public announcement with respect
               to, or otherwise make any public statement concerning,
               the transactions contemplated by this Agreement without
               the consent of the other party, which consent shall not
               be unreasonably withheld.

                         9.13.  Assignment; No Third Party
               Beneficiaries.  Neither this Agreement nor any of the
               rights, interests or obligations hereunder shall be
               assigned by any of the parties hereto (whether by
               operation of law or otherwise) without the prior written
               consent of the other parties.  Subject to the preceding
               sentence, this Agreement will be binding upon, inure to
               the benefit of and be enforceable by the parties and
               their respective successors and assigns.  Except as
               otherwise expressly provided herein, this Agreement
               (including the documents and instruments referred to
               herein) is not intended to confer upon any person other
               than the parties hereto any rights or remedies hereunder.

                         IN WITNESS WHEREOF, Buyer and the Company have
               caused this Agreement to be executed by their respective
               officers thereunto duly authorized as of the date first
               above written.

                                         NORTH FORK BANCORPORATION, INC.

                                         By /s/  John Adam Kanas             
                                            Name:   John Adam Kanas
                                            Title:  Chairman, President &
                                                    Chief Executive Officer

               Attest:

               /s/  Anthony J. Abate     
               Name: Anthony J. Abate
                     Vice President & Secretary

                                         METRO BANCSHARES INC.

                                         By /s/  David G. Herold             
                                            Name:   David G. Herold
                                            Title:  Chairman and Chief
                                                    Executive Officer

               Attest:

               /s/  Stephen G. Wilson    
               Name:  Stephen G. Wilson
                      Chief Financial Officer






          THE TRANSFER OF THIS AGREEMENT IS
          SUBJECT TO CERTAIN PROVISIONS CONTAINED
          HEREIN AND TO RESALE RESTRICTIONS UNDER
          THE SECURITIES ACT OF 1933, AS AMENDED

          STOCK OPTION AGREEMENT

                    STOCK OPTION AGREEMENT, dated as of June 27,
          1994 (the "Agreement"), by and between Metro Bancshares
          Inc., a Delaware corporation ("Issuer"), and North Fork
          Bancorporation, Inc., a Delaware corporation ("Grantee").

                    WHEREAS, Grantee and Issuer have entered into
          an Agreement and Plan of Merger (the "Merger Agreement"),
          of even date herewith, providing for, among other things,
          the merger of Issuer with and into Grantee; and 

                    WHEREAS, as a condition and inducement to
          Grantee's execution of the Merger Agreement, Grantee has
          requested that Issuer agree, and Issuer has agreed, to
          grant Grantee the Option (as defined below);

                    NOW, THEREFORE, in consideration of the
          foregoing and the respective representations, warranties,
          covenants and agreements set forth herein and in the
          Merger Agreement, and intending to be legally bound
          hereby, Issuer and Grantee agree as follows:

                    1.   Defined Terms.  Capitalized terms which
          are used but not defined herein shall have the meanings
          ascribed to such terms in the Merger Agreement.

                    2.   Grant of Option.  Subject to the terms and
          conditions set forth herein, Issuer hereby grants to
          Grantee an irrevocable option (the "Option") to purchase
          up to 557,795 shares (subject to adjustment as set forth
          herein) (the "Option Shares") of common stock, par value
          $0.01 per share, of Issuer ("Issuer Common Stock") at a
          purchase price (subject to adjustment as set forth
          herein) of $21.00 per Option Share (the "Purchase
          Price").

                    3.   Exercise of Option.  (a)  Grantee may
          exercise the Option, in whole or in part, at any time and
          from time to time following the occurrence of a Purchase
          Event (as defined below); provided, however, that the
          Option, to the extent not previously exercised, shall
          terminate and be of no further force and effect upon the
          earliest to occur of (i) the Effective Time, (ii) 12
          months after the first occurrence of a Purchase Event (as
          defined below), (iii) termination of the Merger Agreement
          in accordance with the terms thereof prior to the
          occurrence of a Purchase Event (other than a termination
          of the Merger Agreement by Grantee pursuant to Section
          8.1(f) thereof) or (iv) 12 months after the termination
          of the Merger Agreement by Grantee pursuant to Section
          8.1(f) thereof, provided, however, that if within 12
          months after a termination of the Merger Agreement by
          Grantee pursuant to Section 8.1(f) thereof a Purchase
          Event shall occur, then notwithstanding anything to the
          contrary contained herein, this Option shall terminate 12
          months after the first occurrence of such Purchase Event;
          and provided further, however, that any purchase of
          shares upon exercise of the Option shall be subject to
          compliance with applicable law, including, without
          limitation, the Bank Holding Company Act of 1956, as
          amended (the "BHC Act"); and provided further, however,
          that if the Option cannot be exercised on any day because
          of any injunction, order or similar restraint issued by a
          court of competent jurisdiction, the period during which
          the Option may be exercised shall be extended so that the
          Option shall expire no earlier than on the 10th business
          day after such injunction, order or restraint shall have
          been dissolved or when such injunction, order or
          restraint shall have become permanent and no longer
          subject to appeal, as the case may be.

                         (b)  As used herein, a "Purchase Event"
          means any of the following events:

                              (i)  Issuer shall have
               authorized, recommended, publicly proposed or
               entered into an agreement with any person
               (other than Grantee or any affiliate of Grantee
               or any person acting in concert in any respect
               with Grantee) to effect an Acquisition
               Transaction (as defined below), shall have
               failed to publicly oppose any such Acquisition
               Transaction or shall have failed to publicly
               oppose a Tender Offer or an Exchange Offer (as
               defined below).  As used herein, the term
               Acquisition Transaction shall mean (A) a
               merger, consolidation or similar transaction
               involving Issuer or any of its Subsidiaries
               (other than internal mergers, reorganizations,
               consolidations or dissolutions involving only
               existing Subsidiaries), (B) the disposition, by
               sale, lease, exchange or otherwise, of assets
               of Issuer or any of its Subsidiaries
               representing 20% or more of the consolidated
               assets of Issuer and its Subsidiaries or (C)
               the issuance, sale or other disposition of
               (including by way of merger, consolidation,
               share exchange or any similar transaction)
               securities representing 20% or more of the
               voting power of Issuer or any of its
               Subsidiaries;

                              (ii)  any person (other than
               Grantee or any affiliate of Grantee or any
               person acting in concert in any respect with
               Grantee) shall have acquired Beneficial
               Ownership (as such term is defined in Rule 13d-
               3 promulgated under the Securities Exchange Act
               of 1934, as amended (the "Exchange Act")) of,
               or the right to acquire Beneficial Ownership
               of, or any Group (as such term is defined under
               the Exchange Act) shall have been formed which
               shall have acquired Beneficial Ownership of, or
               the right to acquire Beneficial Ownership of,
               20% or more of the then outstanding shares of
               Issuer Common Stock;

                              (iii)  any person (other than
               Grantee or any affiliate of Grantee or any
               person acting in concert in any respect with
               Grantee) shall have commenced (as such term is
               defined in Rule 14d-2 under the Exchange Act)
               or shall have filed a registration statement
               under the Securities Act of 1933, as amended
               (the "Securities Act") with respect to, a
               tender offer or exchange offer to purchase any
               shares of Issuer Common Stock such that, upon
               consummation of such offer, such person would
               own or control 20% or more of the then
               outstanding shares of Issuer Common Stock (such
               an offer being referred to herein as a "Tender
               Offer" or an "Exchange Offer," respectively);

                              (iv)  the holders of Issuer
               Common Stock shall not have approved the Merger
               Agreement and the transactions contemplated
               thereby, at the meeting of such stockholders
               held for the purpose of voting on such
               agreement, or such meeting shall not have been
               held or shall have been cancelled prior to
               termination of the Merger Agreement, in each
               case after it shall have been publicly
               announced that any person (other than Grantee
               or any affiliate of Grantee or any person
               acting in concert in any respect with Grantee)
               shall have made, or disclosed an intention to
               make, a proposal to engage in an Acquisition
               Transaction; or

                              (v)  Issuer's Board of Directors
               shall not have recommended to the stockholders
               of Issuer that such stockholders vote in favor
               of the approval of the Merger Agreement and the
               transactions contemplated thereby or shall have
               withdrawn or modified such recommendation in a
               manner adverse to Grantee.

          As used in this Agreement, "person" shall have the
          meaning specified in Sections 3(a)(9) and 13(d)(3) of the
          Exchange Act.

                         (c)  In the event Grantee wishes to
          exercise the Option, it shall send to Issuer a written
          notice (the date of which being herein referred to as the
          "Notice Date") specifying (i) the total number of Option
          Shares it intends to purchase pursuant to such exercise
          and (ii) a place and date not earlier than three business
          days nor later than 30 business days from the Notice Date
          for the closing (the "Closing") of such purchase (the
          "Closing Date").  If prior notification to or approval of
          the Board of Governors of the Federal Reserve System (the
          "Federal Reserve Board") or any other regulatory
          authority is required in connection with such purchase,
          Issuer shall cooperate in good faith with Grantee in the
          filing of the required notice or application for approval
          and the obtaining of any such approval and the period of
          time that otherwise would run pursuant to the preceding
          sentence shall run instead from the date on which, as the
          case may be (i) any required notification period has
          expired or been terminated or (ii) such approval has been
          obtained, and in either event, any requisite waiting
          period shall have passed.

                         (d)  Notwithstanding anything to the
          contrary in this Agreement, Grantee shall not exercise
          this Agreement if it is in material breach of the Merger
          Agreement.

                    4.   Payment and Delivery of Certificates.  (a) 
          On each Closing Date, Grantee shall (i) pay to Issuer, in
          immediately available funds by wire transfer to a bank
          account designated by Issuer, an amount equal to the
          Purchase Price multiplied by the number of Option Shares
          to be purchased on such Closing Date and (ii) present and
          surrender this Agreement to the Issuer at the address of
          the Issuer specified in Section 12(f) hereof.  In
          addition to any other amounts payable pursuant to this
          Section 4(a), upon the first exercise of the Option,
          Grantee shall pay an amount, if any, by which (i)
          $2,000,000 plus the product of (A) the total number of
          Option Shares and (B) the difference between the
          Market/Tender Offer Price (as defined below) and the
          Purchase Price exceeds (ii) $4,500,000 provided, however,
          that in no event shall the amount payable pursuant to
          this sentence exceed $2,000,000.  As used herein, the
          "Market/Tender Offer Price" shall mean the higher of the
          highest per share at which a Tender Offer or Exchange
          Offer has been made by any person other than Grantee or
          any affiliate of Grantee or person acting in concert in
          any respect with Grantee for at least 20% of the shares
          of Issuer Common Stock then outstanding or the highest
          closing sales price per share of Issuer Common Stock
          quoted on the American Stock Exchange ("AMEX") (or if
          Issuer Common Stock is not quoted on the AMEX, the
          highest bid price per share as quoted on the principal
          trading market or securities exchange on which such
          shares are traded as reported by a recognized source)
          within the six-month period immediately preceding this
          Agreement.

                         (b)  At each Closing, simultaneously with
          the delivery of immediately available funds and surrender
          of this Agreement as provided in Section 4(a) hereof,
          Issuer shall deliver to Grantee (A) a certificate or
          certificates representing the Option Shares to be
          purchased at such Closing, which Option Shares shall be
          free and clear of all liens, claims, charges and
          encumbrances of any kind whatsoever, other than any such
          lien or encumbrance created by Grantee and (B) if the
          Option is exercised in part only, an executed new
          agreement with the same terms as this Agreement
          evidencing the right to purchase the balance of the
          shares of Issuer Common Stock purchasable hereunder.  If
          Issuer shall have issued rights or any similar securities
          ("Rights") pursuant to any shareholder rights, poison
          pill or similar plan (a "Shareholder Rights Plan") prior
          or subsequent to the date of this Agreement and such
          Rights remain outstanding at the time of the issuance of
          any Option Shares pursuant to an exercise of all or part
          of the Option hereunder, then each Option Share issued
          pursuant to such exercise shall also represent the number
          of Rights issued per share of Issuer Common Stock with
          terms substantially the same as and at least as favorable
          to Grantee as are provided under the Shareholder Rights
          Plan as then in effect.

                         (c)  Certificates for the Option Shares
          delivered at each Closing shall be endorsed with a
          restrictive legend which shall read substantially as
          follows:

               THE TRANSFER OF THE STOCK REPRESENTED BY THIS
               CERTIFICATE MAY BE SUBJECT TO RESTRICTIONS
               ARISING UNDER THE SECURITIES ACT OF 1933, AS
               AMENDED, AND PURSUANT TO THE TERMS OF A STOCK
               OPTION AGREEMENT DATED AS OF JUNE 27, 1994.  A
               COPY OF SUCH AGREEMENT WILL BE PROVIDED TO THE
               HOLDER HEREOF WITHOUT CHARGE UPON RECEIPT BY
               THE ISSUER OF A WRITTEN REQUEST THEREFOR.

          It is understood and agreed that the above legend shall
          be removed by delivery of substitute certificate(s)
          without such legend if Grantee shall have delivered to
          Issuer a copy of a letter from the staff of the
          Securities and Exchange Commission (the "SEC"), or an
          opinion of outside counsel reasonably satisfactory to
          Issuer in form and substance reasonably satisfactory to
          Issuer and its counsel, to the effect that such legend is
          not required for purposes of the Securities Act.

                    5.   Representations and Warranties of Issuer. 
          Issuer hereby represents and warrants to Grantee as
          follows:

                         (a)  Due Authorization.  Issuer has full
          corporate power and authority to enter into this
          Agreement and to consummate the transactions contemplated
          hereby.  The execution and delivery of this Agreement and
          the consummation of the transactions contemplated hereby
          have been duly authorized by all necessary corporate
          action on the part of Issuer.  This Agreement has been
          duly and validly executed and delivered by Issuer.

                         (b)  No Violation.  Neither the execution
          and delivery of this Agreement, nor the consummation of
          the transactions contemplated hereby, nor compliance by
          Issuer with any of the terms or provisions hereof, will
          (i) violate any provision of the Certificate of
          Incorporation (the "Certificate of Incorporation") or By-
          Laws of Issuer or the certificates of incorporation, by-
          laws or similar governing documents of any of its
          Subsidiaries or (ii) (x) assuming that all of the
          consents and approvals required under applicable law for
          the purchase of shares upon the exercise of the Option
          are duly obtained, violate any statute, code, ordinance,
          rule, regulation, judgment, order, writ, decree or
          injunction applicable to Issuer or any of its
          Subsidiaries, or any of their respective properties or
          assets, or (y) violate, conflict with, result in a breach
          of any provisions of or the loss of any benefit under,
          constitute a default (or an event which, with notice or
          lapse of time, or both, would constitute a default)
          under, result in the termination of or a right of
          termination or cancellation under, accelerate the
          performance required by, or result in the creation of any
          lien, pledge, security interest, charge or other
          encumbrance upon any of the respective properties or
          assets of Issuer or any of its Subsidiaries under, any of
          the terms, conditions or provisions of any note, bond,
          mortgage, indenture, deed of trust, license, lease,
          agreement or other instrument or obligation to which
          Issuer or any of its Subsidiaries is a party, or by which
          they or any of their respective properties or assets may
          be bound or affected.

                         (c)  Authorized Stock.  Issuer has taken
          all necessary corporate and other action to authorize and
          reserve and to permit it to issue, and, at all times from
          the date of this Agreement until the obligation to
          deliver Issuer Common Stock upon the exercise of the
          Option terminates, will have reserved for issuance, upon
          exercise of the Option, shares of Issuer Common Stock
          necessary for Grantee to exercise the Option, and Issuer
          will take all necessary corporate action to authorize and
          reserve for issuance all additional shares of Issuer
          Common Stock (together with any Rights which may have
          been issued with respect thereto) or other securities
          which may be issued pursuant to Section 7 upon exercise
          of the Option.  The shares of Issuer Common Stock to be
          issued upon due exercise of the Option, including all
          additional shares of Issuer Common Stock (together with
          any Rights which may have been issued with respect
          thereto) or other securities which may be issuable
          pursuant to Section 7, upon issuance pursuant hereto,
          shall be duly and validly issued, fully paid and
          nonassessable, and shall be delivered free and clear of
          all liens, claims, charges and encumbrances of any kind
          or nature whatsoever  (except any such lien or
          encumbrance created by Grantee), including any preemptive
          rights of any stockholder of Issuer.

                         (d)  Board Action.  By action of the Board
          of Directors of Issuer prior to the execution of this
          Agreement, resolutions were duly adopted approving the
          execution, delivery and performance of this Agreement,
          any purchase or other transaction respecting Issuer
          Common Stock provided for herein, and the other
          transactions contemplated hereby.  Accordingly, the
          provisions of Section 203 of the Delaware General
          Corporation Law as they relate to Issuer and Section 8 of
          Issuer's Certificate of Incorporation do not and will not
          apply to this Agreement or any of the other transactions
          contemplated hereby.

                    6.   Representations and Warranties of Grantee. 
          Grantee hereby represents and warrants to Issuer that:

                         (a)  Due Authorization.  Grantee has
          corporate power and authority to enter into this
          Agreement and, subject to any approvals or consents
          referred to herein, to consummate the transactions
          contemplated hereby.  The execution and delivery of this
          Agreement and the consummation of the transactions
          contemplated hereby have been duly authorized by all
          necessary corporate action on the part of Grantee.  This
          Agreement has been duly executed and delivered by
          Grantee.

                         (b)  Purchase Not for Distribution.  This
          Option is not being acquired with a view to the public
          distribution thereof and neither this Option nor any
          Option Shares will be transferred or otherwise disposed
          of except in a transaction registered or exempt from
          registration under the Securities Act.

                    7.    Adjustment upon Changes in
          Capitalization, etc.  (a) In the event (i) of any change
          in Issuer Common Stock by reason of a stock dividend,
          stock split, split-up, recapitalization, combination,
          exchange of shares or similar transaction or (ii) that
          any Rights issued by Issuer shall become exercisable, the
          type and number of shares or securities subject to the
          Option, and the Purchase Price therefor, shall be
          adjusted appropriately, and, in the case of any of the
          transactions described in clause (i) above, proper
          provision shall be made in the agreements governing such
          transaction so that Grantee shall receive, upon exercise
          of the Option, the number and class of shares or other
          securities or property that Grantee would have received
          in respect of Issuer Common Stock if the Option had been
          exercised immediately prior to such event, or the record
          date therefor, as applicable.  If any additional shares
          of Issuer Common Stock are issued after the date of this
          Agreement (other than pursuant to an event described in
          the first sentence of this Section 7(a)), the number of
          shares of Issuer Common Stock subject to the Option shall
          be adjusted so that, after such issuance, the Option,
          together with any shares of Issuer Common Stock
          previously issued pursuant hereto, equals 9.9% of the
          number of shares of Issuer Common Stock then issued and
          outstanding, without giving effect to any shares subject
          or previously issued pursuant to the Option.

                    (b)  In the event that Issuer shall enter into
          an agreement (i) to consolidate with or merge into any
          person, other than Grantee or one of its Subsidiaries,
          and shall not be the continuing or surviving corporation
          of such consolidation or merger, (ii) to permit any
          person, other than Grantee or one of its Subsidiaries, to
          merge into Issuer and Issuer shall be the continuing or
          surviving corporation, but, in connection with such
          merger, the then outstanding shares of Issuer Common
          Stock shall be changed into or exchanged for stock or
          other securities of Issuer or any other person or cash or
          any other property or the outstanding shares of Issuer
          Common Stock immediately prior to such merger shall after
          such merger represent less than 50% of the outstanding
          shares and share equivalents of the merged company, or
          (iii) to sell or otherwise transfer all or substantially
          all of its assets to any person, other than Grantee or
          one of its Subsidiaries, then, and in each such case, the
          agreement governing such transaction shall make proper
          provisions so that the Option shall, upon the
          consummation of any such transaction and upon the terms
          and conditions set forth herein, be converted into, or
          exchanged for, an option (the "Substitute Option"), at
          the election of Grantee, of either (I) the Acquiring
          Corporation (as defined below), (II) any person that
          controls the Acquiring Corporation, or (III) in the case
          of a merger described in clause (ii), the Issuer (such
          person being referred to as the "Substitute Option
          Issuer").

                         (c)  The Substitute Option shall have the
          same terms as the Option, provided, that if the terms of
          the Substitute Option cannot, for legal reasons, be the
          same as the Option, such terms shall be as similar as
          possible and in no event less advantageous to Grantee. 
          The Substitute Option Issuer shall also enter into an
          agreement with the then holder or holders of the
          Substitute Option in substantially the same form as this
          Agreement, which shall be applicable to the Substitute
          Option.

                         (d)  The Substitute Option shall be
          exercisable for such number of shares of the Substitute
          Common Stock (as hereinafter defined) as is equal to the
          Assigned Value (as hereinafter defined) multiplied by the
          number of shares of Issuer Common Stock for which the
          Option was theretofore exercisable, divided by the
          Average Price (as hereinafter defined).  The exercise
          price of the Substitute Option per share of the
          Substitute Common Stock (the "Substitute Purchase Price")
          shall then be equal to the Purchase Price multiplied by a
          fraction in which the numerator is the number of shares
          of the Issuer Common Stock for which the Option was
          theretofore exercisable and the denominator is the number
          of shares of the Substitute Common Stock for which the
          Substitute Option is exercisable.

                         (e)  The following terms have the meanings
          indicated:

               (I)  "Acquiring Corporation" shall mean (i) the
          continuing or surviving corporation of a consolidation or
          merger with Issuer (if other than Issuer), (ii) Issuer in
          a merger in which Issuer is the continuing or surviving
          person, and (iii) the transferee of all or substantially
          all of the Issuer's assets (or the assets of its
          Subsidiaries).

               (II)  "Substitute Common Stock" shall mean the
          common stock issued by the Substitute Option Issuer upon
          exercise of the Substitute Option.

               (III)  "Assigned Value" shall mean the highest of
          (i) the price per share of Issuer Common Stock at which a
          tender offer or exchange offer therefor has been made by
          any person (other than Grantee), (ii) the price per share
          of Issuer Common Stock to be paid by any person (other
          than the Grantee) pursuant to an agreement with Issuer,
          and (iii) the highest closing sales price per share of
          Issuer Common Stock quoted on the AMEX (or if Issuer
          Common Stock is not quoted on the AMEX, the highest bid
          price per share as quoted on the principal trading market
          or securities exchange on which such shares are traded as
          reported by a recognized source) within the six-month
          period immediately preceding the agreement; provided,
          however, that in the event of a sale of less than all of
          Issuer's assets, the Assigned Value shall be the sum of
          the price paid in such sale for such assets and the
          current market value of the remaining assets of Issuer as
          determined by a nationally recognized investment banking
          firm selected by Grantee or by a Grantee Majority,
          divided by the number of shares of Issuer Common Stock
          outstanding at the time of such sale.  In the event that
          an exchange offer is made for the Issuer Common Stock or
          an agreement is entered into for a merger or
          consolidation involving consideration other than cash,
          the value of the securities or other property issuable or
          deliverable in exchange for the Issuer Common Stock shall
          be determined by a nationally recognized investment
          banking firm mutually selected by Grantee and Issuer (or
          if applicable, Acquiring Corporation), provided that if a
          mutual selection cannot be made as to such investment
          banking firm, it shall be selected by Grantee (or a
          majority of interest of the Grantees if there shall be
          more than one Grantee (a "Grantee Majority")).

               (IV)  "Average Price" shall mean the average closing
          price of a share of the Substitute Common Stock for the
          one year immediately preceding the consolidation, merger
          or sale in question, but in no event higher than the
          closing price of the shares of the Substitute Common
          Stock on the day preceding such consolidation, merger or
          sale; provided that if Issuer is the issuer of the
          Substitute Option, the Average Price shall be computed
          with respect to a share of common stock issued by Issuer,
          the person merging into Issuer or by any company which
          controls or is controlled by such merging person, as
          Grantee may elect.

                         (f)  In no event, pursuant to any of the
          foregoing paragraphs, shall the Substitute Option be
          exercisable for more than 9.9% of the aggregate of the
          shares of the Substitute Common Stock outstanding prior
          to exercise of the Substitute Option.  In the event that
          the Substitute Option would be exercisable for more than
          9.9% of the aggregate of the shares of Substitute Common
          Stock but for this clause (f), the Substitute Option
          Issuer shall make a cash payment to Grantee equal to the
          excess of (i) the value of the Substitute Option without
          giving effect to the limitation in this clause (f) over
          (ii) the value of the Substitute Option after giving
          effect to the limitation in this clause (f).  This
          difference in value shall be determined by a nationally
          recognized investment banking firm selected by Grantee
          (or a Grantee Majority).

                         (g)  Issuer shall not enter into any
          transaction described in subsection (b) of this Section 7
          unless the Acquiring Corporation and any person that
          controls the Acquiring Corporation assume in writing all
          the obligations of Issuer hereunder and take all other
          actions that may be necessary so that the provisions of
          this Section 7 are given full force and effect
          (including, without limitation, any action that may be
          necessary so that the shares of Substitute Common Stock
          are in no way distinguishable from or have lesser
          economic value than other shares of common stock issued
          by the Substitute Option Issuer).

                         (h)  The provisions of Sections 8 and 9
          shall apply to any securities for which the Option
          becomes exercisable pursuant to this Section 7 and as
          applicable, references in such sections to "Issuer",
          "Option", "Purchase Price" and "Issuer Common Stock"
          shall be deemed to be references to "Substitute Option
          Issuer", "Substitute Option", "Substitute Purchase Price"
          and "Substitute Common Stock", respectively.

                    8.   Registration Rights.  Issuer shall, if
          requested by Grantee (or if applicable, a Grantee
          Majority) at any time and from time to time within three
          years of the date on which the Option first becomes
          exercisable, as expeditiously as possible prepare and
          file up to two registration statements under the
          Securities Act if such registration is necessary in order
          to permit the sale or other disposition of any or all
          shares of Issuer Common Stock or other securities that
          have been acquired by or are issuable to Grantee upon
          exercise of the Option in accordance with the intended
          method of sale or other disposition stated by Grantee,
          including a "shelf" registration statement under Rule 415
          under the Securities Act or any successor provision, and
          Issuer shall use its best efforts to qualify such shares
          or other securities under any applicable state securities
          laws.  Issuer shall use its best efforts to cause each
          such registration statement to become effective, to
          obtain all consents or waivers of other parties which are
          required therefor and to keep such registration statement
          effective for such period not in excess of 180 days from
          the day such registration statement first becomes
          effective as may be reasonably necessary to effect such
          sale or other disposition.  Any registration statement
          prepared and filed under this Section 8, and any sale
          covered thereby, shall be at Issuer's expense except for
          underwriting discounts or commissions, brokers' fees and
          the fees and disbursements of Grantee's counsel related
          thereto.  Grantee shall provide all information
          reasonably requested by Issuer for inclusion in any
          registration statement to be filed hereunder.  If during
          the time periods referred to in the first sentence of
          this Section 8 Issuer effects a registration under the
          Securities Act of Issuer Common Stock for its own account
          or for any other stockholders of Issuer (other than on
          Form S-4 or Form S-8, or any successor forms or any form
          with respect to a dividend reinvestment or similar plan),
          it shall allow Grantee the right to participate in such
          registration, and such participation shall not affect the
          obligation of Issuer to effect two registration
          statements for Grantee under this Section 8; provided,
          however, that, if the managing underwriters of such
          offering advise Issuer in writing that in their opinion
          the number of shares of Issuer Common Stock requested by
          Grantee to be included in such registration, together
          with the shares of Issuer Common Stock proposed to be
          included in such registration, exceeds the number which
          can be sold in such offering, Issuer shall include the
          shares requested to be included therein by Grantee pro
          rata with the shares intended to be included therein by
          Issuer.  In connection with any registration pursuant to
          this Section 8, Issuer and Grantee shall provide each
          other and any underwriter of the offering with customary
          representations, warranties, covenants, indemnification
          and contribution in connection with such registration. 
          Notwithstanding anything to the contrary contained
          herein, in no event shall Issuer be obligated to effect
          more than two registrations pursuant to the first
          sentence of this Section 8 by reason of the fact that
          there shall be more than one Grantee as a result of any
          assignment of this Agreement or division of this
          Agreement pursuant to Section 10 hereof.

                    9.   Listing.  If Issuer Common Stock or any
          other securities to be acquired upon exercise of the
          Option are then authorized for quotation on the AMEX or
          any securities exchange, Issuer, upon the request of
          Grantee, will promptly file an application to authorize
          for quotation the shares of Issuer Common Stock or other
          securities to be acquired upon exercise of the Option on
          the AMEX or such other securities exchange and will use
          its best efforts to obtain approval of such listing as
          soon as practicable.

                    10.  Division of Option.  This Agreement (and
          the Option granted hereby) are exchangeable, without
          expense, at the option of Grantee, upon presentation and
          surrender of this Agreement at the principal office of
          Issuer for other Agreements providing for Options of
          different denominations entitling the holder thereof to
          purchase in the aggregate the same number of shares of
          Issuer Common Stock purchasable hereunder.  The terms
          "Agreement" and "Option" as used herein include any other
          Agreements and related Options for which this Agreement
          (and the Option granted hereby) may be exchanged.  Upon
          receipt by Issuer of evidence reasonably satisfactory to
          it of the loss, theft, destruction or mutilation of this
          Agreement, and (in the case of loss, theft or
          destruction) of reasonably satisfactory indemnification,
          and upon surrender and cancellation of this Agreement, if
          mutilated, Issuer will execute and deliver a new
          Agreement of like tenor and date.  Any such new Agreement
          executed and delivered shall constitute an additional
          contractual obligation on the part of Issuer, whether or
          not the Agreement so lost, stolen, destroyed or mutilated
          shall at any time be enforceable by anyone.

                    11.  Rights Agreement.  Issuer shall not
          approve or adopt, or propose the approval and adoption
          of, any Shareholder Rights Plan unless such Shareholder
          Rights Plan contains terms which provide, to the
          reasonable satisfaction of Grantee, that (a) the Rights
          issued pursuant thereto will not become exercisable by
          virtue of the fact that (i) Grantee is the Beneficial
          Owner of shares of Issuer Common Stock (x) acquired or
          acquirable pursuant to the grant or exercise of this
          Option and (y) held by Grantee or any of its Subsidiaries
          as Trust Account Shares or DPC Shares or (ii) while
          Grantee is the Beneficial Owner of the shares of Issuer
          Common Stock described in clause (a)(i), an Acquisition
          Transaction involving Issuer or any of its Subsidiaries,
          on the one hand, and Grantee, any of its Subsidiaries, on
          the other hand, is proposed, agreed to or consummated and
          (b) no restrictions or limitations with respect to the
          exercise of any Rights acquired or acquirable by Grantee
          will result or be imposed by virtue of the fact that
          Grantee is the Beneficial Owner of the shares of Issuer
          Common Stock described in clause (a)(i) of this Section
          11.  

                    12.  Miscellaneous.  (a)  Expenses.  Except as
          otherwise provided in Section 8 hereof, each of the
          parties hereto shall bear and pay all costs and expenses
          incurred by it or on its behalf in connection with the
          transactions contemplated hereunder, including fees and
          expenses of its own financial consultants, investment
          bankers, accountants and counsel.

                         (b)  Waiver and Amendment.  Any provision
          of this Agreement may be waived at any time by the party
          that is entitled to the benefits of such provision.  This
          Agreement may not be modified, amended, altered or
          supplemented except upon the execution and delivery of a
          written agreement executed by the parties hereto.

                         (c)  Entire Agreement; No Third-Party
          Beneficiary; Severability.  This Agreement, together with
          the Merger Agreement and the other agreements and
          instruments referred to herein and therein, (a)
          constitutes the entire agreement and supersedes all prior
          agreements and understandings, both written and oral,
          between the parties with respect to the subject matter
          hereof and (b) is not intended to confer upon any person
          other than the parties hereto any rights or remedies
          hereunder.  Notwithstanding anything to the contrary
          contained in this Agreement or the Merger Agreement, this
          Agreement shall be deemed to amend the confidentiality
          agreement between Issuer and Grantee so as to permit
          Grantee to enter into this Agreement and exercise all of
          its rights hereunder, including its right to acquire
          Issuer Common Stock upon exercise of the Option.  If any
          term, provision, covenant or restriction of this
          Agreement is held by a court of competent jurisdiction or
          a federal or state regulatory agency to be invalid, void
          or unenforceable, the remainder of the terms, provisions,
          covenants and restrictions of this Agreement shall remain
          in full force and effect and shall in no way be affected,
          impaired or invalidated.  If for any reason such court or
          regulatory agency determines that the Option does not
          permit Grantee to acquire the full number of shares of
          Issuer Common Stock as provided in Section 3 hereof (as
          adjusted pursuant to Section 7 hereof), it is the express
          intention of Issuer to allow Grantee to acquire such
          lesser number of shares as may be permissible without any
          amendment or modification hereof.

                         (d)  Governing Law.  This Agreement shall
          be governed and construed in accordance with the laws of
          the State of Delaware without regard to any applicable
          conflicts of law rules.

                         (e)  Descriptive Headings.  The
          descriptive headings contained herein are for convenience
          of reference only and shall not affect in any way the
          meaning or interpretation of this Agreement.

                         (f)  Notices.  All notices and other
          communications hereunder shall be in writing and shall be
          deemed given if delivered personally, telecopied (with
          confirmation) or mailed by registered or certified mail
          (return receipt requested) to the parties at the
          following addresses (or at such other address for a party
          as shall be specified by like notice):

                    If to Issuer to:

                         Metro Bancshares Inc.
                         100 Jericho Quadrangle
                         Jericho, N.Y.  11753
                         Attention:  David G. Herold

                    with a copy to:

                         Skadden, Arps, Slate, Meagher & Flom
                         919 Third Avenue
                         New York, New York 10022
                         Attention:  Fred B. White, III

                    If to Grantee to:

                         North Fork Bancorporation, Inc.
                         9025 Route 25
                         Mattituck, N.Y.  11952
                         Attention:  Daniel M. Healy

                    with a copy to:

                         Muldoon, Murphy & Faucette
                         5101 Wisconsin Avenue, NW
                         Suite 508
                         Washington, D.C.  20016
                         Attention:  Joe Passaic, Esq.

                         (g)  Counterparts.  This Agreement and any
          amendments hereto may be executed in two counterparts,
          each of which shall be conspidered one and the same
          agreement and shall become effective when both
          counterparts have been signed, it being understood that
          both parties need not sign the same counterpart.

                         (h)  Assignment.  Neither this Agreement
          nor any of the rights, interests or obligations hereunder
          or under the Option shall be assigned by any of the
          parties hereto (whether by operation of law or otherwise)
          without the prior written consent of the other party,
          except that Grantee may assign this Agreement to a wholly
          owned subsidiary of Grantee and after the occurrence of a
          Purchase Event Grantee may assign its rights under this
          Agreement to one or more third parties, provided,
          however, that Grantee may not assign this Agreement,
          without the written consent of Issuer, to any third party
          who, to Grantee's knowledge, would, upon exercise of the
          Option, own in excess of 6% of Issuer's then issued and
          outstanding common stock.  Subject to the preceding
          sentence, this Agreement shall be binding upon, inure to
          the benefit of and be enforceable by the parties and
          their respective successors and assigns.  As used in this
          Agreement, Grantee shall include any person to whom this
          Agreement or the Option shall be assigned by a previous
          Grantee in accordance with the terms hereof.

                         (i)  Further Assurances.  In the event of
          any exercise of the Option by Grantee, Issuer and Grantee
          shall execute and deliver all other documents and
          instruments and take all other action that may be
          reasonably necessary in order to consummate the
          transactions provided for by such exercise.

                         (j)  Specific Performance.  The parties
          hereto agree that this Agreement may be enforced by
          either party through specific performance, injunctive
          relief and other equitable relief.  Both parties further
          agree to waive any requirement for the securing or
          posting of any bond in connection with the obtaining of
          any such equitable relief and that this provision is
          without prejudice to any other rights that the parties
          hereto may have for any failure to perform this
          Agreement.


                    IN WITNESS WHEREOF, Issuer and Grantee have
          caused this Stock Option Agreement to be signed by their
          respective officers thereunto duly authorized, all as of
          the day and year first written above.

                                   METRO BANCSHARES INC.

                                   By/s/  David G. Herold          
                                     Name:  David G. Herold
                                     Title: Chairman and Chief     
                                            Executive Officer

                                   NORTH FORK BANCORPORATION, INC.

                                   By/s/  John Adam Kanas          
                                     Name:  John Adam Kanas
                                     Title: Chairman, President &
                                            Chief Executive Officer




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission